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LITERATURE REVIEW 
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1.1.  THE ECOLOGY OF GASTROINTESTINAL TRACT AT 
WEANING 
 
 
The microbial population of young pigs develops during the first 48 h of life via 
the ingestion of maternal faeces (Makie et al., 1999) or by the contact with the 
sow skin and teats that are usually contaminated (Arboukle, 1968). 
During  the  suckling  period  the  dominant  groups  in  the  upper  part  of  the 
gastrointestinal tract are lactobacilli and streptococci (Jensen, 1998). At birth the 
stomach of piglets is sterile (Sinkovics and Juhasz, 1974), but after few hours 
viable cells of lactobacilli, streptococci, coliforms and clostridia, can be isolated 
from the gastric content. During the following 5-6 days the number of lactobacilli 
and  streptococci  is  around  10
5-10
7  cells  per  gram  of  content  (Jensen,  1998; 
Pluske, 2002) ant it will be stable for all the suckling period. In the proximal small 
intestine  there  is  a  microflora  similar  to  that  of  stomach,  being  therefore 
lactobacilli and streptococci the dominant groups (Jensen, 1998). In contrast the 
distal small intestine, contains an higher number of bacteria (10
8-10
9 cells per 
gram  of  digesta).  Although  determining  the  exact  composition  of  the  large 
intestine microflora is very hard, because of the high number of uncolturable cells, 
King an Kelly (2001) found 10
10-10
11 cells per gr of content in the lumen of colon, 
with  more  of  400  different  colturable  bacterial  species.  Numerous  studies 
conducted on the characterization of large intestine microflora demonstrated that 
the  maior  groups  are  Streptococcus,  Lactobacillus,  Prevotella,  Selenomona, 
Mitsokuella,  Megasphera,  Clostridia,  Eubacteria,  Bacteroides,  Fusobacteria, 
Acidodaminicocci, and Enterobacteria (Salanitro et a., 1977; Allison et al., 1979; 
Russel, 1979; Robinson et al., 1981; Moore et al., 1987; Jensen, 2001; and Pluske 
et al., 2002). Although detailed studies on the microflora in the hindgut have been 
conducted, there is evidence of a great diversity between animals and between 
different studies  results, since the variability in number or type of cells depends 
on  the  nutrients  availability  in  the  gut,  being  nutrients  limiting  factors  which 
support the growth of one bacterial strain rather than another one (Gaskins, 2001).   6
At weaning there are many changes which interfere with the normal microbial 
populations. Jensen (1998) investigated the effect of weaning on microbial counts, 
pH, and dry matter  of digesta. In that study it was observed that during the first 2-
4 days after weaning pH and dry matter content of fecal samples and lactobacilli 
counts decreased, whereas, concurrently, coliforms counts increased. This tends to 
make the pig susceptible to diarrhea scouring and poor growth performance. In 
the same study  piglets were sacrificed at weaning (28 days), 6 days and 20 days 
after  weaning,  and  samples  from  different  intestinal  tracts  were  collected  to 
measure pH, dry matter, and  microbial determination and activity through ATP 
concentration. The results demonstrated that the microflora of piglets after 6 days 
from  weaning  was  different  from  the  other  groups,  since  there  was  an  higher 
number of coliforms cells and a lower number of lactobacilli in each intestinal 
segment.  Animals  sacrificed  20  days  after  weaning  presented  a  significantly 
higher microbial activity in the large intestine, as demonstrated by lower pH and 
higher ATP concentration. These results conducted Jensen to conclude that the 
microbiota  of  piglets  is  instable  until  3  weeks  after  weaning,  when  the  large 
intestine fermentative capacity is fully developed. 
 
 
1.2.   HEALTH  IMPLICATION  OF  MICROFLORA  IN  THE 
HOST  AND  IMPACT  OF  ANTIBIOTIC  GROWTH 
PROMOTERS  (AGP)  ON  THE  ECOLOGY  OF  THE 
GASTROINTESTINAL TRACT  
 
 
The  major  health  implications  of  the  gut  flora  vary  widely  ranging  from  the 
production  of  toxic,  carcinogenic  or  mutagenic  metabolites  from  substances 
derived from the diet or produced endogenously, to the detoxification of dietary 
toxicants, to immunostimulation (Link-Amster et al., 1994; Marteau et al., 1997), 
to intestinal permeability (Isolauri et al., 1993; Mao et al., 1996), and to confer 
colonization  resistance  towards  pathogens  and  a  consequent  prevention  of 
diarrhoea (Raza et al., 1995).   7
Intestinal fermentations prevalently occur in the hind gut (Decuypere and Van der 
Heyde,  1972)  where  decarboxylation  of  several  amino  acids  by  bacteria  can 
produce monoamines and polyamines (Guggenheim, 1951; Dierick et al., 1986). 
that can exert toxic effects in different species (Lean et al., 1989; Cole et al., 
1995).  Furthermore  the  intestinal  microflora  is  also  deeply  involved  in  the 
production of ammonia. Ammonia is produced both by endogenous and bacterial 
enzymes within the alimentary tract. Bacterial enzymes appear to produce 75% of 
the alimentary tract ammonia with urea hydrolysis being the major contributor in 
mammals  residing  in  conventional  nongerm-free  environments  (Visek,  1984). 
Energy is the fermentation limiting factor in the hind gut (Orskov et al., 1970). As 
energy  sources  (starch  and  fermentable  carbohydrates)  are  depleted,  the 
fermentation becomes more and more proteolytic. This results in ammonia and 
amines production (Russell et al., 1983); ammonia destroys cells, alters nucleic 
acid synthesis, increases intestinal mucosal cell mass, increases virus infections, 
favors growth of cancerous cells over noncancerous cells in tissue culture (Visek, 
1978) and reduces the villus height (Nousiainen, 1991). Absorbed ammonia must 
be excreted as urea with an energy cost of approximately 7% of the total energy 
expenditure  in  monogastric  as  well  as  in  ruminant  animals  (Eisemann  and 
Nienaber,  1990)  influencing  the  metabolism  and  resulting  in  reduced  animal 
performance (Visek, 1984).  
The growth promoting effects of introducing antimicrobials in animal diets have 
been known from decades, since Stokstad and Jukes (1949) demonstrated that the 
presence of tetracyclin residues in poultry feed increased the growth of animals. 
Improved  growth  performance  following  the  use  of  antibiotics  were  then 
described in turkeys (Stokstad and Jukes, 1950), pigs (Jukes et al., 1950), and 
ruminants (Jukes and Williams, 1953; Stokstad, 1954). From that time the use of 
antibiotics as growth factors has become widespread. 
The major benefits derived from the use of subtherapeutic doses of antibiotics in 
animal feeding were: disease prevention, improved feed utilization, and increased 
growth rate. These effects were more evident in younger, stressed animals (Hays, 
1969) and where management and hygiene conditions were worse. Especially in 
pigs, most feed antibiotics were used in newly weaned piglets, a critical time for   8
infection in these young animals, and only to a lesser extent in older pigs being 
raised for slaughter, where their use was generally regarded as unnecessary and 
not cost effective. 
Feed antibiotics occasionally have been shown to reduce the number of bacteria 
present in the gut (Jensen, 1988) but more often to have little effect on total counts 
of viable bacteria. 
Several researchers observed that animals receiving diets added with antibiotics 
showed similarities with germ free animals (Stutz et al., 1983; Nousiainen, 1991): 
reduced gut weight and length, thinner intestinal wall, and reduced cell turnover in 
the gut mucosa. Although a final explanation for these effects has not been found 
yet,  they  surely  are  related  to  changes  in  the  composition  of  the  intestinal 
microflora. The mechanism by which the antibiotic growth promoters act is not 
known by certainty, but several hypotesis have been made:1) a reduction in the 
thickness  of  the  intestinal  mucosa  and,  as  a  consequence,  a  more  efficient 
absorption of nutrients; 2) energy and nutrients are spared because of a reduction 
of competitors microorganisms; 3) the production of discrete lesions in the cell 
wall  of  enteric  bacteria  and  the  reduction  of  microorganism  responsible  for 
intestinal  disorders;  4)  a  reduction  in  amounts  of  bacterial  toxins  and  toxic 
metabolites  produced  in  the  intestine;  5)  an  increase  in  intestinal  alkaline 
phosphatase levels; 6) a decrease in the level of production of intestinal ammonia; 
7) a reduction of microbial deconjugation of bile salts. ( Jensen, 1998). 
Since the introduction of AGP in animal husbandry, an increasing concern on the 
widespread of antibiotic resistant microorganisms conducted Europe toward the 
ban  of  AGP,  as  of  January  1
st  ,  2006;  this  led  researchers  to  find  alternative 
molecules  to  be  used  in  animal  production  which  act  antibiotic-like,  whithout 
being a threat to human health.    9
 
1.3.  FEEDING STRATEGIES TO REDUCE THE IMPACT OF 
POST WEANING SYNDROME 
 
 
Weaning is a very crucial moment in the growth of pigs; there are many factors 
which  contribute  to  the  rise  of  gut  infections,  which  have  an  high  economic 
impact  in  pigs  husbandry,  especially  after  the  removal  of  antibiotic  growth 
promoters (AGP). These infections are commonly called Post Weaning Syndrome 
(PWS) or Post Weaning Colibacillosis (PWC) (Pluske et al., 2002) since it seems 
to be E. coli the main cause of such syndrome. Even if it has been demonstrated 
that E. coli is necessary for diarrhea outbreaks, PWS is nowadays regarded as a 
multifactorial disease (Dirkzwager et al., 2005; Pluske et al., 2002) which needs 
many  cofactors  playing  important  roles  in  predisposing  to  its  development. 
Among these “causative agents” we can list environmental factors, such as the 
separation from the mother, the regrouping of animals, the exposure to a new 
antigenic environment, and the “cold- stress” due to the lack of thermoregulation 
capacity  (Wathes  et  al.,  1989).  All  those  factors  contribute  to  make  piglets 
stressed  with  a  consequent  higher  production  of  cortisol    which,  via  the 
sympathetic nervous system, alters the intestinal transit time and  causes immune 
suppression (Pluske et al., 2002). Furthermore the piglets during weaning loose 
any passive antibody protection provided from the sow’s milk. Anorexia and feed 
refusal  are  important  consequences  of  stressful  weaning  and  contribute  in 
worsening the yet dramatic situation. 
In addition to that there are other factors, such as physiological factors as the 
passage  from  liquid  to  solid  feed.  The  possibilities  for  maximizing  sow 
productivity  and  the  need  to  more  efficiently  utilize  the  expensive  farrowing 
facilities have led pig producers to wean piglets at three-four weeks of age. At that 
time the GIT and its digestive enzymes set are not fully developed (Dirzwager et 
al., 2003; Marion et al., 2002), the bacterial colonization is still transient and the 
piglets result more exposed and sensitive to anti-nutritional factors present in a 
vegetable  diet,  being  therefore  more  susceptible  to  mal-absorption.  The  first   10
consequence  is  a  larger  amount  of  undigested  feed  in  the  intestine,  which 
represent  a  good  substrate  for  microorganism  overgrowth  (Dirkzwager  et  al., 
2005; Hopwood et al., 2003).  
Acid secretion in young pigs does not reach appreciable levels until 3-4 weeks 
after weaning (Cranwell and Moughan, 1989). The suckling pig employs several 
strategies to overcome the limitation of insufficient acid secretion and these have 
been discussed by Easter (1988). The primary strategy involves the conversion of 
lactose  in  sow’s  milk  to  lactic  acid  by  Lactobacilli  bacteria  residing  in  the 
stomach. Secondly, the nursing pig reduces the need for transitory secretion of 
copious amounts of acid by frequent ingestion of small meals. Finally, diets are 
known  to  differ  widely  in  acid-buffering  capacity:  this  capacity  is  lowest  in 
cereals and cereal by-products, intermediate or high in protein feedstuffs and very 
high in mineral sources, except in dicalcium and monosodium phosphates (Jasaitis 
et al., 1987). 
The  failure  to  maintain  a  low  gastric  pH  has  major  implications  for  the 
performance  of  the  early-weaned  pig.  First,  an  elevated  pH  would  cause  a 
reduction in the activation of pepsinogen which occurs rapidly at pH 2 and very 
slowly at pH 4 (Taylor, 1962). The pepsins have two optimal pH, 2 and 3.5, and 
their activity declines above 3.6 with no activity at pH > 6.0 (Taylor, 1959). As a 
result,  feed  proteins  may  enter  the  small  intestine  essentially  intact  with  an 
eventual reduction in efficiency of protein digestion. The end-products of pepsin 
digestion also stimulate the secretion of pancreatic proteolytic enzymes (Rerat, 
1981). Furthermore acid from the stomach is the primary stimulant for pancreatic 
secretion of bicarbonate (Kidder and Manners, 1978). In addition, acid leaving the 
stomach  plays  a  role  in  the  feedback  mechanism  in  the  regulation  of  gastric 
emptying, thus, decreasing the digesta load on the small intestine. Secondly, an 
acid gastric condition is believed to have pronounced bactericidal properties for 
certain microorganisms, in particular for the Coliforms (Sissons, 1989). Viable 
microorganisms  entering  the  digestive  tract  via  the  mouth  are  unable  to  pass 
through the acidic conditions of the stomach and successfully colonize the small 
intestine. A rise in gastric pH would, therefore, allow increased proliferation of 
Escherichia coli (Smith and Jones, 1963) which has been associated with scours   11
and increased mortality (White et al., 1969; Thomlinson and Lawrence, 1981). 
Furthermore,  evidence  suggests  that  proliferation  of  Coliforms  in  the  stomach 
may lead to further diminution of gastric acid secretion due to the release of a 
bacterial polysaccharide with an inhibitory effect on acid secretion (Baume et al., 
1967; Wyllie et al., 1967). 
All the above cited circumstances, e.g. stress, anorexia, and physiology, cause 
great  damages  to  the  intestinal  mucosa,  which  undergoes  to  several  structural 
changes  such  as  the  reduction  of  villi  height  and  an  increase  in  crypts  depth 
(Pluske  et  al.,  1996).  The  reduction  of  the  intestinal  absorptive  area  and  the 
appearance of a less mature enterocyte population help to explain the increased 
susceptibility  of  the  pig  to  diarrhoea.  In  fact  in  the  small  intestine,  nutrients, 
electrolytes, and water are absorbed by villus enterocytes, whereas electrolytes 
and water are secreted in crypt cells (Powell, 1987). Because shorter villi and 
deeper crypts have fewer absorptive and more secretory cells, absorption might be 
poorer and secretion increased. A heat-stable toxin (toxin b) produced by some 
Escherichia coli strains is known to be villus shortening (Whipp et al., 1986). 
During a study on weaned pigs, Nabuurs et al. (1993) recovered an Escherichia 
coli  strain  that  produced  heat-stable  toxin  b  from  all  the  litters  affected  by 
diarrhoea. 
Genetic also could play a key role in PWC syndrome, since it has been studied 
that certain pigs do not express glycoproteic receptors for E. coli K88 fimbriae in 
the brush border of cells lining the intestinal villi in the small intestine (Hampson, 
1994). 
In this context practical feeding and management strategies can be adopted in 
order to ameliorate post weaning conditions and piglets health status. 
 
1.3.1. Improvement of gut development at weaning.  
 
Stimulate  feed  intake  before  and  after  weaning  by  supplying  a  palatable  diet 
during  the  first  5-10  days  is  a  very  important  tool  in  help  a  normal  gut 
development;  the  light  management  can  significantly  influence  this  parameter, 
since during the dark period the ingestion is depressed (Dirkzwager et al., 2005).   12
Another strategy could be to supply the diet with substrates like butyrate, which is 
known to be an intestinal mucosa growth factor (Piva et al., 2002).  
 
1.3.2. Improvement of feed digestion.  
 
The  choice  of  right  ingredients,  highly  digestible  nutrient  sources,  is  a  very 
important tool in controlling PWS associated intestinal microbial proliferation. 
Numerous studies investigated the correlation between the inclusion of soluble 
NSP in piglets starter diets and the proliferation of E. coli. Feeding piglets with 
pearl barley meal increased intestinal viscosity and altered microbial fermentation, 
helping E. coli proliferation both in small and large intestines as demonstrated by 
Mc Donald et al. (2001b). These data suggests that the presence of soluble NSP in 
weaner diets is an undesirable effect, which can be overcome by selecting cereals 
low  in  NSP  content  or  adding  exogenous  enzymes,  such  as  b-glucanases,  or 
xilanases, to increase soluble NSP digestibility.  
The  source  of  proteins,  such  as  vegetable  or  animal  proteins,  is  another  very 
important aspect to be  evaluated, since it has  been demonstrated that  soybean 
meal is rich of anti-nutritional factors that reduce protein digestibility, and induce 
mucosal damages, especially in highly susceptible weanling pigs (Miller et al., 
1984). Proteins of animal origins, such as milk whey or fish meal proteins, are 
therefore preferable to soybean proteins. Hall and Byrne (1989) observed villus 
stunting, loss of activity of lactase and sucrase from the mucosa and reduced live-
weight  gain  in  weaning  pigs  when  the  diet  was  changed  from  milk  to  a  dry 
pelleted  meal  feed  containing  milk,  soya  and  cereal  proteins,  without  any 
interactions with microbial pathogens. They supposed, that the intestinal damage 
detected could be the result of antibody-mediated damage induced by antibodies 
to soya proteins in the meal. 
Nutritionists  have  attempted  to  overcome  the  digestive  inefficiency  of  early 
weaned pigs by incorporating milk products in cereal/oilseed meal based diets. 
Milk products of high quality have consistently improved postweaning growth 
performances  (Pals  and  Ewan,  1978;  Graham  et  al.,  1981;  Cera  et  al.,  1988). 
These beneficial effects arise from their high content of lactose (Mahan, 1992)   13
which  is  not  only  more  digestible  than  the  complex  carbohydrates  from  plant 
sources, but is also fermented to lactic acid to provide gastric acidity (Wilson and 
Leibholz, 1981) and to act as a non-digestible oligosaccharide (Piva et al., 1998). 
Protein diet concentration is another critical factor. High proteins levels in starters 
diets  may  result  in  large  amounts  of  free  AA  available  for  microflora 
fermentations  with  final  production  of  polyamines  (putrescine,  cadaverine, 
histamine, etc..) which are implicated in PWS. Typical starters diets contains up to 
25% crude proteins/dry matter with an average digestibility of 75-85% (Pluske et 
al., 2002). A 7 kg piglet, can eat up to 60 gr proteins/day , a 25% of which can by-
pass small intestine digestion and reach the lower hindgut, where it is rapidly 
fermented  by  proteolytic  microflora,  such  as  Bacteroides,  Clostridium, 
Enterobacterium, Streptococcus, to poly-amines and gas and ammonia, that seem 
to be implicated in PWS (Aumaitre et al., 1995; Pluske et al., 2002).  
Improvement  of  colonization,  which  means  to  select  a  stable  and  positive 
microflora in the animal, by  adding probiotics  and prebiotics to the diet.  It is 
possible that resident bacteria in the gut, antagonistic to other invading bacteria, 
may  contribute  to  infection  resistance  by  competitive  exclusion  (Lloyd  et  al., 
1977) or by the production of metabolites which have antibacterial effects on the 
pathogens. 
Although  the  definition  of  probiotics  presents  considerable  problems  and  has 
varied over the years, the final aim of their application is that probiotics should 
have beneficial effects on animals by the establishment of an optimum balance of 
microbes  in  the  alimentary  tract.  Salminen  et  al.  (1996)  have  summarized  the 
most  important  functional  effects  of  probiotics:  these  include  aspects  such  as 
immune  modulation  and  strengthening  the  gut  mucosal  barrier,  due  to:  1)  gut 
microflora modification; 2) adherence to the intestinal mucosa with capacity to 
prevent  pathogen  adherence  or  pathogen  activation;  3)  modification  of  dietary 
proteins by the intestinal microflora; 4) modification of bacterial enzyme capacity, 
especially of those suggested to be related to tumour induction; 5) influence on 
gut mucosal permeability. 
 Prebiotics  or  non  digestible  oligosaccharides  (NDO)  are  carbohydrates  that 
escape enzymatic digestion in the small intestine and form a substrate  for the   14
gastrointestinal  microflora.  NDO  can  modify  the  composition  of  the  intestinal 
microflora by selectively stimulating the growth and/or activity of one or a limited 
number of bacteria, as for example inulin, which can be fermented by strains of 
lactic  acid  bacteria  and  Bifidoacterium  in  a  preferential  way  (Gibson  and 
Roberfroid, 1995). Many  NDO display bifidogenic properties  and increase the 
bifidobacteria  counts  in  different  sections  of  the  gastrointestinal  tract  and/or 
faeces (Tanaka et al., 1983; Mutai et al., 1984; Hidaka et al., 1986; Hayakawa et 
al., 1990). Several investigators have shown that NDO are able to decrease the 
concentration of ammonia and putrefactive products in the hind gut of man and 
monogastric  animals  (Gibson  and  Roberfroid,  1995;  Piva  et  al.,  1996;  Jensen, 
1998). 
 
1.3.3. Improvement of the immune response 
 
 Adding  vitamins,  antioxidants,  PUFA,  and  antibody  derived  from  plasmatic 
proteins to the diet could be a tool in controlling PWS consequences. 
 
1.3.4. Inhibition of the growth of pathogenic bacteria 
 
Adding organic acids to the diet causes the pH decline in the gut and may inhibit 
the  growth  of  E.  coli  pH-sensitive  and  improve  stomach  functionality  by 
decreasing its empting rate, while supplementing the diet with essential oils or 
plant derivatives, which have well known antimicrobial properties (Burt, 2004) 
can reduce intestinal pathogens shedding.   15
 
1.4.  REPLACING ANTIBIOTIC GROWTH PROMOTERS 
 
 
1.4.1. Organic acids 
 
Positive  effects  on  the  performance  of  weanling  pigs  have  been  achieved  by 
adding  organic  acids  or  their  salts  to  the  feed.  Some  physical  and  chemical 
properties of organic acids that are used as acidifiers in pig diets are presented in 
Table 1.1. 
 
Table 1.1. Formulas, physical and chemical characteristics of organic acids used 
as dietary acidifiers for pigs (Foegeding and Busta, 1991) 
Acid  Formula  MM
a  Density  Form  pKa 
    g/mol  g/mL     
Formic  HCOOH  46.03  1.220  liquid  3.75 
Acetic  CH3COOH  60.05  1.049  liquid  4.76 
Propionic  CH3CH2COOH  74.08  0.993  liquid  4.88 
Butyric  CH3CH2CH2COOH  88.12  0.958  liquid  4.82 
Lactic  CH3CH(OH)COOH  90.08  1.206  liquid  3.83 
Sorbic  CH3CH:CHCH:CHCOOH  112.14  1.204  solid  4.76 
Fumaric  COOHCH:CHCOOH  116.07  1.635  solid  3.02 
          4.38 
Malic  COOHCH2CH(OH)COOH  134.09    liquid  3.4 
          5.1 
Tartaric  COOHCH(OH)CH(OH)COOH  150.09  1.760  liquid  2.93 
          4.23 
Citric  COOHCH2C(OH)(COOH)CH2COOH  192.14  1.665  solid  3.13 
          4.76 
          6.40 
aMM, molecular mass expressed in grams 
   16
Dietary  acidification  reduces  the  buffering  capacity  of  the  diet  and  this  may 
support a more efficient proteolysis of digesta in the stomach and therefore result 
in  a  higher  protein  digestibility  of  the  diet.  Addition  of  organic  acids  reduces 
dietary pH curvilinearly depending on the acid pKa value and buffering capacity 
of the diet. The pH-lowering effect of different organic acids is reduced in the 
following order: tartaric acid > citric acid > malic acid > fumaric acid > lactic and 
formic  acid  >  acetic  acid  >  propionic  acid.  Organic  salts  have  only  a  small 
influence on dietary pH (Partanen and Mroz, 1999). 
Eckel  et  al.  (1992)  observed  that  formic  acid  supplementation  positively 
influenced nutrient digestibility. Improvements were higher for protein (up to 4%) 
than for energy (up to 2%) and were more pronounced in a period short after 
weaning than at a later age. 
Conversely, other researchers (Falkowski and Aherne, 1984; Bolduan et al., 1988; 
Radecki et al., 1988) have reported no improvements in the digestibility of dry 
matter or nitrogen when organic acids were fed. Mosenthin et al. (1992) reported 
that  apparent  ileal  digestibility  of  nitrogen  was  not  affected  by  propionic  acid 
supplementation.  However,  propionic  acid  addition  significantly  improved 
apparent  ileal  digestibility  of  arginine,  histidine,  leucine,  phenylalanine  and 
valine. 
Organic  acids  exert  various,  specific  antimicrobial  properties.  Formic  acid  for 
example acts against yeasts and certain bacterial species, such as Bacillus spp., 
Escherichia coli and Salmonella, but lactobacilli and moulds are rather resistant to 
formic acid (Rehm, 1961). This antibacterial effect might be explained by the 
protons (H
+ ions) and anions (HCOO
- ions) into which formic acid is divided after 
passing the bacterial cell wall and which have  a disruptive effect on bacterial 
protein synthesis (Lück, 1986). There is some evidence from the literature that 
fumaric and propionic acid, as well as formic acid, decrease intestinal microbial 
growth (Bolduan et al., 1988; Sutton et al., 1991; Gedek et al., 1992). 
While travelling through the gastrointestinal tract neutralophiles, like Escherichia 
coli, Salmonella typhimurium or Shigella flexneri, must endure the extreme, low 
pH of the stomach as well as the short chain fatty acids present in the intestine and 
faeces. Figure 1.1 shows how pH varies through the gastrointestinal tract; Figure   17
1.2 shows the amount of volatile fatty acids (VFA) in the different sections of the 
gastrointestinal tract. 
 
 
Figure 1.1. Mean pH in the gastrointestinal contents of the pig (Clemens et al., 1975). 
Symbols  along  the  abscissa  represent  the  sections  of  the  tract  as  follows:  S1,  S2  = 
stomach; SI1, SI2, SI3 = small intestine; C = cecum; PC = proximal colon; C2, C3, C4, 
C5 = colon; TC = terminal colon 
 
 
 
Figure 1.2. Mean volatile fatty acids concentration in segments of the pig gastrointestinal 
tract (Dukes, 1990). 
Symbols  along  the  abscissa  represent  the  sections  of  the  tract  as  follows:  S1,  S2  = 
stomach; SI1, SI2, = small intestine; C = cecum; C1, C2, C3 = colon 
 
These bacteria are, therefore, exposed to acid stress, which can be described as the 
combined  biological  effect  of  low  pH  and  weak  organic  acids  present  in  the 
environment.  Weak  acids,  including  those  produced  as  a  result  of  intestinal 
fermentation, can diffuse across the cell membrane in the uncharged, protonated 
form and dissociate inside the cell, lowering internal pH  (pHi; Bearson et al., 
1997). The lower the external pH (pHe), the more undissociated weak acid will be   18
available  (based  upon  pKa  values)  to  cross  the  membrane  and  affect  pHi.  To 
overcome the lowering of pHi, several amino acid decarboxylases are induced; 
these elevate the pHi by consuming a proton during decarboxylation and they then 
exchange the decarboxylation end-product for a new substrate via a membrane-
bound  antiporter  (Bearson  et  al.,  1997).  One  example  is  lysine  decarboxylase 
(CadA) coupled with the lysine-cadaverine antiporter (CadB) of S. typhimurium. 
The  CadA  decarboxylates  intracellular  lysine  to  cadaverine  and  consumes  a 
proton in the process.  Cadaverine is then  exchanged for  fresh lysine from the 
surrounding  environment  via  the  CadB  antiporter  (Park  et  al.,  1996).  Similar 
inducible  systems,  with  arginine  and  glutamate  decarboxylases,  have  been 
described for Escherichia coli (Lin et al., 1995). 
Russel (1991a,b) observed that bacteria that can tolerate fermentation acids at low 
pH have relatively small transmembrane pH gradients (DpH). 
Since organic acids are able to pass the bacterial cell wall in their undissociated 
more lipophilic form, their rate of dissociation is very important. The effect of pH 
on  organic  acid  dissociation  is  given  by  the  Henderson-Hasselbach  equation, 
where A
- and HA are the dissociated and undissociated species, respectively 
pHe = pKa + log[A
-]/[HA]. Figure 1.3 shows how the rate of dissociation of the 
acid depending on the pKa. 
 
Figure 1.3 [HA] % in relation to pH 
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At neutral pH, there is very little HA, but HA increases logaritmically as the pH 
declines. Because fermentation acids are generally more toxic to bacteria at low 
pH, it has generally been assumed that the antimicrobial activity of fermentation 
acids was caused by HA molecules (Salmond et al., 1984). But HA is membrane-
permeable and it never accumulates; only fermentation anions seem to have the 
ability to accumulate intracellularly depending on pHi: by high pHi more acid 
becomes  dissociated  and  the  anions  accumulate  (Russell  and  Diez-Gonzalez, 
1998). 
Russell  and  Diez-Gonzalez  (1998)  theorized  the  DpH-mediated  model  of 
fermentation acid toxicity, where anions accumulation is DpH dependent  
DpH=log ([A
-] + [HA])in/([A
-] + [HA])out ) 
This model is supported by a variety of observations: intracellular acetate anion 
seems to be in equilibrium with DpH (Diez-Gonzalez and Russell, 1998); bacteria 
(e.g. Escherichia coli) that are highly sensitive to fermentation acids have high 
DpH values at acidic pH (Salmond et al., 1984; Wallace et al., 1989); bacteria 
(e.g. lactobacilli and streptococci) that are highly resistant to fermentation acids 
seem to have low DpH values (Russell and Hino, 1985; Kashket, 1987; Olsen et 
al., 1991). 
Russell and Diez-Gonzalez (1998) observed that low DpH prevents fermentation 
acid anion accumulation, but there are limits to this strategy for growth, and that 
cells  that  have  higher  concentrations  of  intracellular  potassium  as  a  potential 
countercation  (Gram-positive  bacteria)  would  be  able  to  accumulate  higher 
concentrations of fermentation anions, and the decrease in intracellular pH would 
not have to be so great. Virtually all bacteria have a constitutive, low-affinity 
potassium  transport  system  that  operates  as  a  potassium/proton  symport 
mechanism.  This  electrogenic  system  is  able  to  dissipate  DpH  (Kashket  and 
Barker,  1977).  Kajikawa  and  Russell  (1992)  observed  that  passive  potassium 
efflux  is  a  mechanism  for  increasing  membrane  potential  and,  based  on  this 
observation,  theorized  a  potassium-dependent  system  of  DpH  and  membrane 
potential  interconversion.  If  a  bacterium  has  a  very  high  concentration  of 
intracellular potassium, membrane potential remains high and DpH is low, and 
vice versa. This scheme is supported by a contrast between lactic acid bacteria and   20
Escherichia coli. The lactic acid bacteria, Streptococcus bovis and Lactobacillus 
lactis,  always  had  very  high  internal  potassium  concentrations  and  never 
generated  large  DpH  values  (Cook  and  Russell,  1994).  Escherichia  coli,  a 
bacterium with lower intracellular potassium levels, was able to decrease DpH as 
the environment became more acidic (Kaback, 1990). Potassium addition caused 
an almost immediate increase in the intracellular pH of Escherichia coli cells that 
were suspended in a medium at acidic pH (Kroll and Booth, 1983). 
Among the monocarboxylic organic acids formic (Eckel et al., 1992), lactic (Roth 
et al., 1993) and sorbic acid (Kirchgessner et al., 1995) showed the best results on 
weanling pig performances. Supplementing weanling pig diets with acetic (Roth 
and  Kirchgessner,  1988)  or  propionic  acid  (Kirchgessner  and  Roth,  1982a) 
improved performance to a much lower extent or not at all. Potential reasons for 
the variable results are: the kind of acid, the dose level, a depressive effect on feed 
intake and the health status of the animals. Within the dose ranges used, formic 
acid at 12, lactic acid at 16 and sorbic acid at 24 g/kg of feed were the most 
effective and may therefore be regarded as the optimal doses. Table 1.2 shows 
some results for monocarboxylic organic acids in piglet feeding trials.   21
 
Table 1.2. The effect of monocarboxylic acid supplementation on weanling pig 
performance 
Acid  %
1  BW
2  DWG
3  %D D D D
4  FCR
5  %D D D D
6  Reference 
Formic  0.6  6.1  463  +21.8*  1.46*  -5.6  Eckel et al., 1992 
  1.2  6.1  468  +22.1*  1.43*  -7.5   
  1.8  6.1  401  +4.6  1.53  -1.0   
  2.4  6.1  325  -15.1*  1.60  +3.9   
               
Acetic  0.9  5.6  415  -2.1  1.77  +1.1  Roth  and  Kirchgessner, 
1988 
  1.8  5.6  429  +1.2  1.72  -1.7   
  2.7  5.6  441  +4.0  1.70  -2.9   
               
Propionic  1.0  5.6  388  -3.2  1.78  +1.1  Kirchgessner  and  Roth, 
1982a 
  2.0  5.6  385  -4.0  1.80  +2.2   
  3.0  5.6  395  -1.5  1.74  -1.1   
               
Lactic  0.8  6.8  489  +4.7  1.65  +1.2  Roth et al., 1993 
  1.6  6.8  505  +8.1  1.60  -1.8   
  2.4  6.8  501  +7.3  1.60  -1.8   
               
Sorbic  1.2  7.2  490  +13.7*  1.63*  -4.1  Kirchgessner et al., 1995 
  1.8  7.2  523  +21.3*  1.60*  -5.9   
  2.4  7.2  546  +26.7*  1.59*  -6.5   
1inclusion level of acid in the diet 
2initial body weight, kg 
3average daily weight gain, g 
4percentage increase/decrease in DWG relative to control 
5feed conversion rate as g feed per g weight gain 
6percentage improvement (-)/deterioration (+) in FCR relative to control 
*significantly different (P<0.05) from control   22
 
Besides these monocarboxylic acids, which (apart from sorbic acid) are products 
of  bacterial  metabolism  in  the  intestinal  tract,  acids  which  are  natural 
intermediates of the citric acid cycle of the cells are also used for supplementing 
piglet  feeds.  Several  investigators  have  reported  improvements  in  starter  pig 
performance  when  either  fumaric  or  citric  acid  was  added  to  the  diet 
(Kirchgessner  and  Roth,  1982b;  Falkowski  and  Aherne,  1984;  Burnell  et  al., 
1988). Kirchgessner et al. (1993) reported improved pig performances also when 
malic acid was used. In contrast to these results, supplementing the diets with 
tartaric acid did not improve pig performances (Kirchgessner et al, 1993). Table 
1.3 shows some results for di-/tricarboxylic organic acids in piglet feeding trials.   23
 
Table 1.3. The effect of di-/tricarboxylic acid supplementation on weanling pig 
performance 
Acid  %
1  BW
2  DWG
3  %D D D D
4  FCR
5  %D D D D
6  Reference 
Fumaric  0.5  7.8  513  -8.4  1.53  -2.0  Kirchgessner and Roth, 1976 
  1.0  7.8  559  +0.1  1.50  -3.9   
  2.0  7.8  625*  +11.6  1.45*  -7.0   
  4.0  7.8  581  +3.8  1.48*  -5.1   
               
Citric  0.5  13.9  443  +4.7  1.98  -4.8  Kirchgessner  and  Roth-
Maier, 1975 
  1.5  13.9  403  -4.7  2.19  +5.2   
  4.5  13.9  502  +18.7*  1.90*  -8.7   
               
Malic  1.2  6.5  465  +4.0  1.59*  -3.6  Kirchgessner et al., 1993 
  1.8  6.5  452  +1.1  1.59*  -3.6   
  2.4  6.5  456  +2.0  1.57*  -4.8   
               
Tartaric  1.2  6.6  449  -7.2  1.64  -3.0  Kirchgessner et al., 1993 
  1.8  6.6  453  -6.4  1.65  -2.4   
  2.4  6.6  433  -10.5  1.64  -3.0   
1inclusion level of acid in the diet 
2initial body weight, kg 
3average daily weight gain, g 
4percentage increase/decrease in DWG relative to control 
5feed conversion rate as g feed per g weight gain 
6percentage improvement (-)/deterioration (+) in FCR relative to control 
*significantly different (P<0.05) from control 
 
In  recent  years,  organic  salts  have  been  coming  more  and  more  under 
consideration as dietary supplements because they are easier to handle, doses can 
be  more  accurately  measured,  and  they  are  less  corrosive  than  the  free  acids. 
Formates,  as  well  as  free  formic  acid,  have  been  demonstrated  to  improve 
performance of weanling pigs: this improvement was reported for sodium formate 
(Kirchgessner  and  Roth,  1987a),  for  calcium  formate  (Kirchgessner  and  Roth,   24
1990),  and  for  potassium  diformate  (Paulicks  et  al.,  1996).  However  neither 
sodium nor calcium formate were as efficient growth promoters as free formic 
acid.  These  neutral  reacting  salts  are  more  efficient  if  they  are  used  in 
combination with the free acid (Kirchgessner and Roth, 1990). Table 4 shows 
some results for formates in piglet feeding trials. 
Attempts  to  improve  pig  performances  using  inorganic  acids  have  met  with 
disappointing results. The use of hydrochloric acid, sulfuric acid and phosphoric 
acid in weaner diets was investigated by Giesting and Easter (1986). Hydrochloric 
acid resulted in severe depressions in intake and growth, sulfuric acid depressed 
feed efficiency, phosphoric acid improved growth and feed efficiency in one trial, 
but was without any effect in a subsequent one. Similar observations were made 
by  Roth  and  Kirchgessner  (1989)  who  reported  no  effect  of  phosphoric  acid 
addition on postweaning performance. 
 
1.4.2. Plant extracts and essential oils 
 
Plant extracts are one of the oldest additives used by mankind. For thousands of 
years herbs and spices have provided flavorings properties to food and many have 
been  used  for  their  antimicrobial  properties  to  preserve  food.  Some  of  most 
common plants known for their antibacterial properties are garlic, onion, thyme, 
basil, cumin, and bay. Among this plants there are also spices, that have been used 
in the past to cover unpleasant odours of unfresh meat, and, at the same time, 
antimicrobial, such as cinnamon and cloves. These natural microbial compounds 
are found in different parts of the plant, such as stems, leaves, barks, and flowers, 
that usually are scented (Lis-Balchin, 2003).  
Plant  extract  contains  a  very  wide  number  of  active  substances  in  variable 
amounts  differing  for  composition  and  chemical  structures,  depending  on  the 
extraction method and on the plant cultivar. All the characteristic which influence 
plant extract composition affect their chemical properties and effect; it is generally 
accepted,  therefore,  for  practical  application,  to  work  with  their  pure  derived 
substances,  naturally  derived  or  chemically  synthetized,  e.g  with  essential  oils 
(EO) or natural identical flavors (NIF).   25
Although  EO  are  known  for  their  antimicrobial  properties,  they  seem  to  have 
additional “side” effects: 1) changes in immune function (Boyaka et al., 2001) 2) 
stimulatory effect on pancreatic secretions (Platel and Srivasan , 1996, 2000); 3) 
antifungal (Mahmoud, 1994); 4) antiviral (Garcia et al., 2003); 5) antitoxigenic 
activity (Sakagami et al., 2001); 5) antioxidant activity (Dorman et al., 2000b). 
The antimicrobial properties of essential oils have been reviewed by many authors 
in the past, but only in recent times attempts to identify the bioactive principles 
have  been  made  (Dorman  and  Deans,  2000),  and  following  this  studies  a 
correlation  between  the  antimicrobial  activity  of  a  compound  and  its  %  in  an 
essential oil, its chemical structure, functional groups and configuaration has been 
made  (Dorman  and  Deans,  2000).  In  Table  1.4  are  presented  the  principal 
structures producing antimicrobial activity in plant extracts an referenced modes 
of action. 
 
Table 1.4: chemical structures involved in antimicrobial action of EO and 
mechanism of action (adapted from Cowan, 1999) 
Class  Subclass  Mechanism of action 
Phenols  Phenols and phenolic acids  Enzyme inactivations (1) 
Membrane un-stabilizers (2) 
  Quinones  Irreversible  union  to  adhesins, 
mb  polypeptides  and  enzymes 
those become inactive (3) 
  Flavonoids,  Flavones,  and 
Flavonols 
 
  Tannins   1, 2, 3 and metal chelators 
  Coumarins  Interaction with eukaryote DNA 
Terpenoids     
Alkaloids    Insertion  in  cellular  wall  or  in 
DNA structures 
Lectins 
Polypeptides 
  Block  of  viral  fusion  and 
absorption 
Di-sulphur bridges formation 
Polyacetilens    unknown 
   26
Essential  oils  are  volatile  compounds  usually  obtained  by  steam  distillation, 
although  a  solvent  extraction  can  be  made  also.  Since  they  are  hydrophobic 
substance they are insoluble in water and soluble in organic solvents. 
EO  comprise  a  great  numbers  of  individual  components,  maior  component 
constitute up to 85% of an EO, while the minor components can be present in 
traces  although  their  presence  seem  involved  in  the  antimicrobial  activity  by 
acting  synergically  with  the  maior  constituent  (Burt,  2004).  The  phenolic 
compounds are generally responsible for the greatest antimicrobial action. The 
composition  in  EO  of  a  plant  is  not  always  constant,  as  it  can  differ  among 
geographical regions or harvesting seasons (Cosentino et al., 1999; Marino et al., 
1999; Juliano et al., 2000; Faleiro et al., 2002); it has been demonstrated that EO 
from  plant  harvested  in  summer,  immediately  after  flowering,  have  an  higher 
antimicrobial power (McGimpsey et al., 1994; Marino et al., 1999); the part of the 
plant from which the EO is extracted can also influence its composition (Delaquis 
et  al.,  2002).  In  Table  1.5  are  presented  the  maior  constituents  of  the  most 
common EO with antibacterial properties.   27
Table 1.5. Maior constituents of EO (from Burt, 2004) 
Common 
name of EO 
Latin name of 
plant source 
Major 
components 
Approximate 
% 
composition
b 
References 
         
Cilantro   Coriandrum 
sativum 
(immature 
leaves)  
Linalool  
E-2-decanal 
26%  
20% 
(Delaquis et al., 2002) 
         
Coriander 
 
Coriandrum 
sativum (seeds) 
Linalool  
E-2-decanal 
70%  (Delaquis et al., 2002) 
         
Cinnamon   Cinnamomum 
zeylandicum 
Trans 
cinnamaldehyde 
65%    (Lens- Lisbonne et al., 
1987) 
         
Oregano   Origanum 
vulgare 
Carvacrol  
Thymol  
g-Terpinene 
Cymene  
 
Trace-80% 
Trace-64% 
2-52% 
Trace-52% 
(Lawrence, 1984; 
Prudent et al., 1995; 
Charai et al., 1996; 
Sivropoulou et al., 1996; 
Kokkini et al., 1997; 
Russo et al., 1998; 
Daferera et al., 2000; 
Demetzos and 
Perdetzoglou, 2001; 
Marino et al., 2001) 
 
         
Rosemary 
 
Rosmarinus 
officinalis 
 
a-pinene  
Bornyl acetate  
Camphor  
1,8-cineole  
 
2 –25% 
0 –17% 
2 –14% 
3 –89% 
(Daferera et al., 2000, 
2003; Pintore et al., 
2002) 
         
Sage  
 
Salvia 
officinalis L.   
Camphor  
a-Pinene  
h-pinene  
1,8-cineole  
a-tujone  
 
6 –15% 
4 – 5% 
2 –10% 
6 –14% 
20–42% 
 
(Marino et al., 2001) 
 
         
Clove  
 
Syzygium 
aromaticum 
Eugenol  
Eugenyl acetate  
 
75–85% 
8 –15% 
(Bauer et al., 2001) 
         
Thyme  
 
Thymus 
vulgaris 
Thymol  
Carvacrol 
g-Terpinene  
p-Cymene  
 
10–64%  
l 2 – 11% 
2 –31% 
10–56% 
(Lens-Lisbonne et al., 
1987; McGimpsey et al., 
1994; Cosentino et al., 
1999; Marino et al., 
1999; Daferera et al., 
2000; Juliano et al., 
2000) 
 
bPercentages of total volatiles rounded up to the nearest whole number 
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There  is  abundant  literature  on  EO  antimicrobial  activity  in  vitro  against 
foodborne pahogens, but  a standardised method to test that substances  has not 
been developed. The minimum inhibitory concentration (MIC) is cited by most 
researchers as a measure of the antibacterial actitivity of EO. The definition of the 
MIC  differs  between  publications  and  this  is  another  obstacle  to  comparison 
between studies. Some MIC values of most common constituents of EO against 
foodborne pathogens are presented in table 1.6.   29
 
Table 1.6. Selected MIC of EO components against foodborne pathogens 
(adapted from Burt, 2004) 
EO 
component 
 
Species of bacteria 
 
MIC 
(µl
-1)
b 
 
References 
 
       
a-Terpineol  E. coli 
S. tiphimurium 
S. aureus 
L. monocytogenes 
B. cereus 
0.45– >0.9 
0.22 
0.9 
>0.9 
0.9 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
       
Carvacrol  E. coli 
S. tiphimurium 
S. aureus 
L. monocytogenes 
0.22– 5 
0.22– 0.25 
0.17– 0.45 
0.37– 5 
Kim et al., 1995a; Cosentino et 
al., 1999 
Kim et al., 1995a; Cosentino et 
al., 1999 
Cosentino et al., 199; Lambert et 
al.,2001  
Kim et al., 1995a; Cosentino et 
al., 199 
       
Citral  E. coli 
S. tiphimurium 
S. aureus 
L. monocytogenes 
B. cereus 
0.5 
0.5 
0.5 
0.5 
0.18– 0.9 
Kim et al., 1995a 
Kim et al., 1995a 
Onawamni et al., 1989 
Kim et al., 1995a 
Cosentino et al., 1999 
       
Eugenol  E. coli 
S. tiphimurium 
L. monocytogenes 
1 
0.5 
>1 
Kim et al., 1995a 
Kim et al., 1995a 
Kim et al., 1995a 
       
Geraniol 
 
E. coli 
S. tiphimurium 
L. monocytogenes 
0.5 
0.5 
1.0 
Kim et al., 1995a 
Kim et al., 1995a 
Kim et al., 1995a 
       
Thymol 
 
E. coli 
S. tiphimurium 
S. aureus 
L. monocytogenes 
B. cereus 
0.22– 0.45 
0.056 
0.14– 0.22 
0.45 
0.45 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
Cosentino et al., 1999 
b
 In the references MICs have been reported in the units mg ml
-1, % (v/v), and mmol l
-1, 
Ag ml_ 1 and mmol l
-1. For ease of comparison these have been converted to µg ml
-1, 
whereby it was assumed that EOs have the same density as water (Burt, 2004). 
 
Considering the large numbers of constituents of EO, it must be supposed that 
their antimicrobial activities is not related to a specific mechanism of action but 
rather to several targets in the microbial cell (Skandamis et al., 2001; Carson et 
al., 2002). The sites of action of EO are illustrated from Fig. 1.3.   30
 
 
Fig. 1.3. Locations and mechanisms in the bacterial cell thought to be sites of action for 
EO  components:  degradation  of the  cell  wall (Thoroski  et  al.,  1989;  Helander  et  al., 
1998); damage to cytoplasmic membrane (Knobloch et al., 1989; Sikkema et al., 1994; 
Oosterhaven et al., 1995; Ultee et al., 2000a, 2002); damage to membrane proteins (Juven 
et  al.,  1994;  Ultee  et  al.,  1999);  leakage  of  cell  contents  (Oosterhaven  et  al.,  1995; 
Gustafson et al., 1998; Helander et al., 1998; Cox et al., 2000; Lambert et al., 2001); 
coagulation of cytoplasm (Gustafson et al., 1998) and depletion of the proton motive 
force (Ultee and Smid, 2001; Ultee et al., 1999). From Burt (2004. 
 
 
It is supposed that EO acts through two different mechanism of action: the first is 
related to their hydrophobicity which allow them to insert in the phospholipid 
bilayer  and  the  second  is  related  to  the  inhibition  of  bacterial  enzymes  and 
receptors  through  their  union  with  specific  sites.  Through  their  hydrophobic 
structure  EO  are  able  to  disrupt  the  bacterial  membrane  and  to  change  its 
permeability (Knobloch et al., 1989; Sikkema et al., 1994; Oosterhaven et al., 
1995; Ultee et al., 2000, 2002); this causes a ion efflux from the inner cell to the 
external medium (Oosterhaven et al., 1995; Gustafson et al., 1998; Helander et al., 
1998; Cox et al., 2000; Lambert et al., 2001). The ion leakage is usually coupled 
with other cytoplasmic constituents leakage, and until a certain amount of loss it 
can be tolerated by the bacterial cell without loss of viability, but, if the efflux is 
longer prolonged, it will cause cell to collapse. The importance of the hydroxyl 
group in determining the antimicrobial power has been confirmed, since it has 
been  found  that  phenolic  compounds,  such  as  thymol  and  carvacrol,  have  the 
higher  antimicrobial  activity  (Dorman  and  Deans,  2000;  Ultee  et  al.,  2002). 
Furthermore it has been established that EO can act on the proteins linked to the   31
cytoplasmic membrane (Knobloch et al., 1989); two possible mechanisms have 
been suggested to explain the interactions of phenols on such proteins. The first 
implies that the hydrocarbons can accumulate in the phospholipid membrane and 
interfere  with  the  lipid-protein  interactions;  the  other  is  that  the  lipohilic 
hydrocarbon can directly interact with hydrophobic parts of the proteins (Juven et 
al., 1994; Sikkema et al., 1995). Another supposed action of EO is the interference 
with cells enzymes: Conner and Beuchat (1984), found that  the presence of EO in 
culture media stimulate the growth of pseudomycelia, as a result of incomplete 
separations  of  newly  formed  cells  in  yeasts,  suggesting  that  EO  may  have 
involved in energy regulation or synthesis of structural constituents. 
The  mode  of  action  of  carvacrol  and  its  analogue,  thymol,  two  of  the  maior 
constituents of oregano and thyme essential oils, have been extensively studied. 
Carvacrol  and  thymol  are  able  to  disintegrate  the  outer  membrane  of  gram-
negative  bacteria,  releasing  lipopolysaccharides  (LPS)  and  increasing  the 
permeability  of  the  cytoplasmic  membrane  to  ATP.  Ultee  et  al.  conducted 
different  studies  on  B.  cereus  in  order  to  investigate  the  mechanism  through 
carvacrol exerts its antibacterial action against gram negative bacteria, and results 
showed that carvacrol dissolves in the phospholipid bilayer aligning between the 
fatty  acid  chains  resulting  in  conformational  changes  of  the  membrane.  A 
disturbance  of  the  van  der  Waals  interactions  between  the  acyl  chains  in  the 
membrane causes an increase in membrane fluidity, which in turn would increase 
passive permeability (Ultee et al., 2002). In the same study the difference between 
cymene, a precursor of carvacrol differing only for the absence of the hydroxyl 
group, and carvacrol has been investigated; to asses the lipophilicity of the two 
substances the Po/w , e.g. the partition coefficient octanol/water has been measured. 
Since cymene resulted to have greater Po/w  values than carvacrol and a lesser 
antimicrobial power it has been postulated that the disgregation of the membrane 
could not be the unique mechanism of action of those molecules, and that another 
factor must be involved. This factor is the presence of the hydroxyl group in the 
carvacrol molecule. The mechanism of action proposed by Ultee et al., (2002) is 
that  carvacrol  act  as  a  transmembrane  carrier  of  monovalent  cations.  The 
characteristic  feature  of  a  phenolic  hydroxyl  group  is  its  significantly  greater   32
acidity than that of an aliphatic hydroxyl group. Substantially it should acts as an 
organic acid do: undissociated phenolic compound pass through the cytoplasmic 
membrane toward the cytoplasm and it dissociate by releasing the proton in the 
cytoplasm. It re-associates by carrying a K
+ ion or any other cation and in that 
form  is  able  to  re-diffuse  through  the  cytoplasmic  membrane  to  the  external 
environment. This hypothesis was supported by the authors by the observed efflux 
of  K
+  and  influx  of  H
+  in  B.  cereus  during  exposure  to  carvacrol.  Similar  to 
carvacrol, thymol contains both a hydroxyl group and a system of delocalized 
electrons  and  was  found  to  possess  strong  antimicrobial  activity.  Juven  et  al. 
(1994) examined the activity of thymol against S. typhimurium and S.  aureus and 
hypothesised  that  thymol  binds  to  membrane  proteins  hydrophobically  and  by 
means of hydrogen bonds, thereby changing the permeability characteristics of the 
membrane; furthermore thymol was found to be more inhibitive at pH 5.5 than 
6.5.  At  a  lower  pH  thymol  would  be  more  undissociated  and  therefore  more 
hydrophobic,  thereby  binding  better  to  the  hydrophobic  areas  of  proteins  and 
dissolve better in the lipid phase (Juven et al., 1994). 
The hypothesized mechanism of action of carvacrol is illustrated in Figure 1.4.   33
 
 
  
Fig 1.4. Schematic overview of hypothesized carvacrol mechanism of action. From Ultee 
et al., (2002a). Undissociated carvacrol pass through the cytoplasmic membrane toward 
the cytoplasm and it dissociate by releasing the proton in the cytoplasm. It re-associates 
by carrying a K
+ ion or any other cation and in that form is able to re-diffuse through the 
cytoplasmic membrane to the external environment. 
 
Conversely to in vitro studies, little is known on the in vivo effect of  essential 
oils. The application of essential oils or their aromatic compounds as alternative to 
AGP in animal production is too recent and there is too little information about 
the actual opportunities of these products. Manzanilla conducted a study (Ph.D 
Thesis,  2005)  on  the  addition  of  a  plant  extract  containg  carvacrol, 
cinnamaldheyde, and capsicum oleoresin to weaner diets with different source and 
concentration  of  proteins.  Although  growth  performance  of  animals  was  not 
affected by the presence of the plant extract, the lactobacilli /Enterobacteriaceae 
ratio in jejunum was shifted toward lactobacilli, thus being related to a lower 
diarrhea incidence. Decreases in E. coli excretion in chickens were obtained with 
the same plant extract by Jamroz et al. (2003). In another study Manzanilla et al.,   34
(2004) observed that the inclusion of plant extract in weaner diet determined again 
an increase in lactobacilli counts, while it tended to reduce Enterobacteriaceae 
counts, resulting in an increase in the lactobacilli/enterobacteriaceae ratio. 
Antimicrobial properties of such compounds are regarded as substituting the AGP 
antibacterial  effect,  but  plant  extract,  essential  oils  and  flavors  have  other 
properties  which  may  help  digestive  functions  in  the  animal,  first  of  all  the 
stimulation of enzymatic secretions (Platel and Srinivasan ,1996, 2000). Since the 
piglets 3 weeks old have an enzymatic set not fully completed, this could be an 
interesting  application  at  weaning  (Kamel,  1999).  For  example  it  has  been 
suggested that a low blood irrigation of stomach may be the cause of a scarce HCl 
secretion (Dunshea, 2003); being capsaicin a vasodilator, this properties could be 
used to improve stomach function of the  animal. Flavors can also modify the 
transit time of digesta (Mikelefield et al., 2000, 2003), and, they can protect the 
intestinal  epithelium  against  aggression  through  their  antioxidant  properties 
(Teissedre and Waterhouse, 2000). 
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Weaning is a very crucial moment in the life of pigs; there are many factors which 
contribute to the rise of gut infections, which have an high economic impact in pig 
husbandry, especially after the removal of antibiotic growth promoters in EU, as 
of January 1
st 2006.  
In this context management and improvement of biosecurity are studied, but the 
development of new nutritional strategies are now the priority. 
The use of organic acids and flavors as alternatives to AGP in animal husbandry 
has been proposed by  many authors. Despite the abundant literature regarding 
antibacterial activities of such substances in in vitro experiments, little data are 
now available on their in vivo effects, especially regarding flavors.  
In this scenario the objectives of this work were: 
1.  to screen the antimicrobial power of different organic acids and flavors 
against  foodborne  pathogens,  which  represent  a  threat  to  both  animal 
productivity and human health, to find possible synergisms among those 
compounds; 
2.  to  evaluate  the  role  of  such  compounds  and  their  possible  synergistic 
effect  in  modulating  swine  intestinal  microflora  in  an  in  vitro  system 
which simulate intestinal environment;  
3.  to  evaluate  substances  under  investigation  in  vivo  as  feed  additive  to 
prevent intestinal disorders during weaning.  
 
To reach these objectives 3 groups of experiments were planned: 
1.  determination of the Minimal Inhibitory Concentration (MIC). The first 
study was planned to assess the MIC of organic acids and flavors against 
Clostridium perfringens and Campylobacter jejuni. The second study was 
to assess the presence of synergism between citric acid and thymol against 
Salmonella enteritidis, Escherichia coli and Clostridium perfringens. 
2.  Intestinal fermentations. The first study was to evaluate the role of citric 
acid, thymol, and three blends of the two substances in modulating the 
small  intestine  microflora  and  fermentation  parameters  in  an  in  vitro 
system  (batch  culture  tecniques).  The  second  study  regarded  the 
investigations of such compounds on the cecal microflora.   37
3.  In  vivo  studies.  In  the  first  study  it  was  evaluated  the  role  of 
microencapsulated citric acid, thymol, and a blend of the two in improving 
piglets  health  status  and  productivity;  the  second  experiment  was  to 
evaluate  a  dose-response  effect  on  feeding  growing  doses  of  a 
microencapsulated blend of citric acid and thymol.   38
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3.1.  DETERMINATION  OF  THE  MINIMAL  INHIBITORY 
CONCENTRATION  OF  ORGANIC  ACIDS  (OA)  AND 
NATURAL IDENTICAL FLAVORS (NIF) OF THE GROWTH 
OF  CLOSTRIDIUM  PERFRINGENS  AND  CAMPYLOBACTER 
JEJUNI. 
 
 
3.1.1. Aim of the study 
 
Aim of this study was to investigate the role of organic acids (OA) and natural 
identical flavors (NIF) as antimicrobial compounds in inhibiting C. perfringens 
and C. jejuni growth in order to study their possible use in animal husbandry to 
reduce microbial infections and microbial carcass contamination at slaughter. 
 
3.1.2. Materials and methods  
 
Bacterial strains and growth conditions 
The bacterial strains used to test the substances in this study were Clostridium 
perfringens  ATCC  13124,  Clostridium  perfringens  field  isolate  (FI)  and 
Campylobacter jejuni ATCC 33291. C. perfringens ATCC 13124 and C. jejuni 
ATCC  33291  were  bought  from  American  Type  Culture  Collection  (ATCC, 
University Boulevard, Manassas, VA, USA); C. perfringens FI was received from 
the University of Montréal, Saint Hyacinthe, QC, curtesy of Dr. Serge Messier, 
Canada stored in cooked meat. After C. perfringens ATCC 13124 and C. jejuni 
have been revitalized according to manufacturer instructions, the master strains 
were  preserved  at  room  temperature  in  Cooked  Meat  (CM  broth,  Difco 
Laboratories, Division of Becton Dickinson and Company, Sparks, MD, USA) for 
Clostridia and at 4°C in Campylobacter Broth (CB broth, Oxoid, Unipath Ltd, 
Basingstoke,  Hampshire,  RG24  OPW)  for  Campylobacter.  Clostridia  working 
seeds were obtained by inoculating  100  L of each stock culture in 10 mL of 
RCM and incubating all at 37°C in anaerobic conditions through two subsequent   40
incubations  of  24  h  ,  while  Campylobacter  was  obtained  using  CB  broth  and 
incubating in microaerophilic conditions.  
Chemicals 
NIF  and  OA  objects  of  the  study  were:  carvacrol  (Fluka),  eugenol  (Fluka), 
salicylaldehyde (Fluka), thymol (Aldrich), vanillin (Fluka) and lactic acid (Fluka), 
all purchased by Sigma-Aldrich Chemie Gmbh, Steinheim, Germany, acetic acid 
(Carlo Erba Reagents, Rodano, Milano, Italy) and, a-chetoglutaric acid, benzoic 
acid,  caprylic  acid,  citric  acid,  formic  acid,  fumaric  acid,  D-gluconic  acid, 
heptanoic  acid,  iso-butyric  acid,  DL-malic  acid,  propionic  acid,  sorbic  acid, 
succinic  acid,  tartaric  acid  and  n-valeric  acid  (Sigma-Aldrich  Corporation,  St. 
Louis, MO, USA). The molecules were diluted in RCM broth for Clostridia tests 
and in CB broth for C. jejuni tests as described below.  
Broth dilution method 
Each  OA  and  NIF  was  diluted  in  RCM  or  CB  broth  in  order  to  obtain  1M 
solutions (stock solutions) except for  benzoic and sorbic acids which were diluted 
at 500 mM, caprylic acid, valeric acid and vanillin which were diluted at 250, 125, 
and 62.5 mM, respectively. Solutions of salicylaldehyde and heptanoic acid at 1 
M, carvacrol and thymol at 125 mM, eugenol were prepared in RCM broth and 
CB  broth  using  £  5%  (v/v)  of  ethanol  (Merck,  Darmstadt,  Germany).  All  the 
solutions were adjusted to pH 6.5 with HCl or NaOH and sterilized using a filter 
with a membrane pore size of 0.45 µm (Stericup/Steritop Filter Unit, Millipore 
Corporation, Bedford, MA, USA). 
Serial two-fold dilutions of each stock solutions were made in RCM and CB broth 
to reach final concentrations of 3.91 mM  and 0.49 mM for media containg OA 
and NIF, respectively.  
Disposable tubes containing 5 ml of test media were inoculated with 10
4 CFU/ml 
of each bacteria. RCM broth cultures were incubated at 37°C for 48h in anaerobic 
conditions;  whereas  CB  broth  cultures  at  42°C  for  48h  in  micro-aerobic 
conditions. As positive control, three tubes containing 5 ml of RCM or CB broth 
without any compound under study were inoculated with the same concentrations 
of microorganism and incubated as previously described, for compound solutions   41
prepared  without  ethanol;  whereas,  dilutions  of  RCM  broth  or  CB  broth  with 
appropriate amount of ethanol but without any compounds were also prepared. 
Optical density (OD) as bacterial growth index was measured after 24 and 48h of 
incubation  using  a  spectrophotometer  (UltroSpec  3000  Pharmacia  Biotech, 
Biochrom, Ltd, Cambridge, UK) at lambda (l) = 600 nm. Broth turbidity at 10
4 
CFU/ml  could  not  be  observed;  increasing  of  turbidity  was  considered  as  a 
positive indicator of bacterial growth after 24 and 48h of incubation. For each 
bacterial strains the growth response was plotted against each concentration of the 
compounds. The minimal inhibitory concentrations (MIC) were determined as the 
lowest  concentration  of  the  substance  tested  which  inhibited  the  increase  of 
turbidity of bacterial cultures after 24 and 48h of incubation. 
Agar test 
Agar plates of RCM and CB were spread with 50 ml of RCM or CB cultures from 
each tube after 24 and 48h of incubation. Plates were incubated for each strain at 
the  same  conditions  of  tubes  and  they  were  read  after  24h  and  48h  to  verify 
visible bacterial growth as to screen bacteriostatic or bactericidal activity of each 
substance under study. 
The MIC were confirmed as the lowest concentration of the specific substance 
which prevents the visible growth of bacteria on agar. 
Statistical analyses  
The experiment was made in triplicate. For each bacterial strain, OD data were 
analyzed for each tested compound by One-way ANOVA; the differences among 
means of groups were obtained using Newman-Keuls t-test based on the variances 
derived from ANOVA (GraphPad Prism 4.0; GraphPad Software, San Diego, CA, 
USA). Differences were considered statistically significant at P<0.05. 
 
3.1.3. Results and discussion 
 
MIC of all the tested substances are shown in the Table 3.1. 
Campylobacter jejuni provided only agar results because of its weak growth, that 
was not detectable by optical density reading. 
Natural identical flavors   42
Eugenol, carvacrol, and thymol were the most effective flavors against all the 
bacterial strains.  
The MIC of eugenol was 15.63, 3.91, and 1.95 mM for C. perfringens ATCC 
13124, C. perfringens FI, and C. jejuni, respectively. Statistical analysis showed 
that concentrations of eugenol below the MIC influenced the extent of growth of 
Clostridia: after 24h it reduced the O.D. of C. perfringens ATCC 13124 (-32%, 
P<0.001) and of C. perfringens FI (-40%, P<0.001) at 1.95 mM.  
The MIC of carvacrol was 15.63, 3.91, and 7.81 mM for C. perfringens ATCC 
13124, C. perfringens FI, and C. jejuni, respectively.   
The MIC of thymol was15.63, 3.91, and 31.25 mM for C. perfringens ATCC 
13124, C. perfringens FI, and C. jejuni, respectively.   
The MIC of salicylaldehyde was 31.25 mM for all the tested strains; even if it has 
been the less effective substance among flavors, it decreased the growth of both 
Clostridium strains (-43%, P<0.001) at 15.63 mM since from 24h of incubation.  
The MIC of vanillin was 15.63 mM for C. perfringens 13124 and 62.5 for both C. 
perfringens FI and C. jejuni. Compared to control, vanillin at 7.81 mM depressed 
the growth of C. perfringens ATCC 13124 (-73%, P<0.001) and of C. perfringens 
FI (-79%, P<0.001) after 24h and of C. perfringens FI (-72%, P<0.001) after 48h. 
At 0.98 mM vanillin was able to contain the growth of C. perfringens FI (–58%, 
P<0.001) either at 24h at 48h.  
Organic Acids 
Organic acids were tested only against C. perfringens 13124 and C. jejuni. α-
chetoglutaric acid was not tested against C. jejuni. 
C. perfringens was  more sensitive to acid action than C. jejuni. Benzoic and 
heptanoic acid were the most effective acids for both the bacterial strains. The 
MIC  of  benzoic  acid  was  31.25  mM  for  both  C.  perfringens  and  C.  jejuni. 
Benzoic acid controlled the growth of C. perfringens ATCC 13124 even at 3.91 
mM (-40%, P<0.001) after 24 h; after 48h, it still induced a decrease of microbial 
OD at 15.63 mM (-71%, P<0.001). 
The MIC of heptanoic acid was 7.81 and 31.24 mM for C. perfringens and C. 
jejuni, respectively. Hepatnoic acid showed to be inhibitory in broth against C. 
perfringens only at 31.25 after 24 and 48 h of incubation, while it was inhibitory   43
at 15.63 and 7.81 mM in agar  after 24h and 48h, respectively, thus showing to 
have inhibitory effect at low concentrations during the 48h duration of the study. 
Heptanoic acid limited the C. perfringens growth until 3.91 mM by -33% and by -
24% (P<0.01) after 24h and 48h, respectively. 
.The MIC of caprilic acid was 7.81 and 62.5 for C. perfringens and C. jejuni. 
Caprilic acid at 3.91 mM in broth was able to reduce the growth of C. perfringens 
by -96% and  -45% (P<0.01) after 24h and 48h, respectively.  
The MIC of citric acid was 62.5 for C. perfringens, while it was not detected until 
1000  mM  for  C.  jejuni.  Citric  acid  at  31.25  mM  was  able  to  decrese  C. 
perfringens OD values after 24h of incubation, but it allowed the growth on agar 
thus showing to have a bacteriostatic effect at that concentration. Citric acid was 
able to contain C. perfringens growth in broth even at 3.91 mM (-71%, P<0.001) 
either at 24h and 48h. 
The MIC of sorbic acid was 31.25 and 500 mM for C. perfringens and C. jejuni, 
respectively. sorbic acid decreased OD values of C. perfringens even at 3.91 mM, 
after  24h  and  48h  by  -42%  and  -37%,  respectively  (P<0.001),  compared  to 
control. 
The  other  acids  showed  a  weaker  action  than  the  prevoius  ones  against  both 
strains, especially against C. jejuni which was resistant to acetic, formic, gluconic, 
iso-butyrric,  lactic,  succinic,  tartaric,  and  valeric  acid    until  1000  mM.  C. 
perfringens was resistant to acetic, α-chetoglutaric, formic, and propionic acid. 
Nevertheless those acids were able to reduce the broth turbidity, such as the viable 
cells of C. perfringens on agar even at lower concentrations than 1000 mM.  
Acetic acid significantly reduced the turbidity until 31.25 mM after 24h, (–63%, 
P<0.001); a-chetoglutaric acid at 250 mM was still able to contain the growth of 
C. perfringens (-80%, P<0.001) after 48h of incubation; formic acid decreased 
OD  values  until  15.63  mM  either  at  24h  (-55%,  P<0.001)  and  48h  (-35%, 
P<0.001); propionic acid limited the growth of C. perfringens even at 3.91 and 
62.50 mM after 24h and 48h, respectively (-11%; -30%, P<0,05) while it was 
inhibiting the growth of C. jejuni at 62.5 mM. 
The MIC of fumaric, D-gluconic, and succinic acid against C. perfringens was 
500 mM.   44
The MIC of DL-malic acid was 125 and 250 mM for C. perfringens and C. jejuni, 
respectively, but it was able to reduce the development of C. perfringens even at 
concentrations  below  the  MIC:  at  62.50  mM  after  24  and  48h  (-98%,  -26%, 
respectively; P<0.05) it exerted a bacteriostatic effect. 
The MIC of lactic and tartaric acid for C. perfringens was 1000 mM. Tartaric acid 
was able to reduce C. perfringens growth until 125 mM after 24h and 48h by -
78% and -80%, respectively (P<0.001).  
The MIC of valeric acid for C. perfringens was 125 mM; after 24h, n-valeric acid 
was able to reduce its growth until 15.63 mM (-17%, P<0.001), whereas, at 48h, 
the acid was able to contain the microbial development until 7.81 mM by -10% 
(P<0.01). 
The MIC of iso-butyric acid for C. perfringens was 500 mM. This acid showed to 
have a bacteriostatic effect at 125 and 250 mM after 24h and 48h of incubation by 
having OD values lower than MIC values; furthermore, after 24h the MIC on agar 
was 250 mM, thus confirming that at 250 mM it acted as a bacteriostatic allowing 
the growth after 48h. 
There  are  numerous  studies  about  bactericidal  activity  of  plant  extracts  and 
organic acids on spoiling bacteria, moulds, and on pathogens such as S. aureus, 
Salmonella  spp.,  E.  coli,  Pseudomonas  aeruginosa,  Bacillus  cereus,  Listeria 
monocytogenes, Yersinia enterocolitica, (Conner and Beuchat, 1984; Galli et al., 
1985; Daouk at al., 1995; Paster et al., 1990; Paster et al., 1995; Sivropoulou  et 
al., 1996; Manou et al., 1998; Burt and Reinders, 2003; Friedman et al., 2002; Lee 
et al., 2004, Peñalver et al., 2005), but few authors studied antimicrobial activity 
of natural inhibitory substances against C. perfringens and C. jejuni up to now 
(Kamel et al., 2000; Strauss et al., 2001; Friedman et al., 2002; Friedman et al., 
2003). 
In  this  study  Clostridia  resulted  more  sensitive  than  C.  jejuni  :  this  could  be 
explained  with  the  fewer  barriers  and  different  structural  and  chemical 
composition  of  the  cells  wall  of  Gram-positive  bacteria  which  results  usually 
more  sensitive  to  inhibition  by  antimicrobials  than  Gram-negative  bacteria 
(Nikaido and Varra, 1985;  Lis-Balchin, 2003).  From data of Si et al.(2006) it 
appears that essential oils/compounds have Gram-negative bacteria specifically as   45
a target, although the authors specified that further investigation is required to 
reach a conclusion; however there are other studies which demonstrate the lack of 
specificity of those compounds toward Gram-positive bacteria rather than Gram-
negative ones (Lis-Balchin, 1998). Dorman and Deans (2001) and Lambert et al. 
(2001)  reported  that  oregano,  which  contains  carvacrol  as  the  main  active 
component,  has  strong  antimicrobial  activity  against  both  Gram-positive  and 
Gram-negative bacterial pathogens. The antimicrobial mechanism of essential oils 
compounds is poorly understood. Current researche on the antimicrobial action of 
phenolic compounds, such as carvacrol and thymol, focuses their attention on cell 
membrane permeability (Davidson, 1997; Ultee et al., 1999) which depends on 
the  hydrophobicity  of  the  solutes  that  have  to  cross  the  membrane  and  on  its 
composition. Partition coefficient of essential oils in cell membrane is determinant 
for  their  effect.  The  hydrophobic  constituents  of  essential  oils  are  capable  of 
accessing to the periplasm of Gram-negative bacteria through the porin proteins 
of the outer membrane (Helander et al., 1998). Carvacrol and thymol can disrupt 
the  outer  membrane  of  bacteria,  causing  the  release  of  membrane-associated 
material from the cell to the external medium and an increased permeability of the 
nucleus. It is thought that membrane perforation or binding is the main mode of 
action of such compounds (Shapiro and Guggenheim, 1995; Strauss and Hayler, 
2001). Structural features such as the aromatic ring (e.g. thymol and carvacrol), or 
the  presence  of  hydroxylic  group  (e.g.  thymol,  carvacrol  and  eugenol)  alter 
polarity and topography of a molecule, therefore changing the affinity to different 
binding  sites  in  the  bacteria  (Si  et  al.,  2006).  Furthermore  Shapiro  and 
Guggenheim  in  their  studies  found  that  hydrophobicity  (water  solubility)  and 
steric  descriptions  (molecular  size  and  shape)  have  important  roles  in  anti-
bacterial activity. 
Kamel (2000) found that clove extract (80% eugenol) at 500 ppm ( 3,05 mM) was 
active in killing 50% of C. perfringens cells. In the same study oregano extract, 
which  contains  from  60%  to  76%  of  carvacrol,  showed  to  be  inhibiting  C. 
perfringens  at  800  ppm  (5.32  mM),  thus  confirming  the  results  of  our  study 
against C. perfringens ATCC 13124 and C. perfringens FI. C. jejuni also was 
inhibited by oregano essential oil at 400 ppm, ( 2,66 mM) which resulted to be a   46
lower value than the one obtained in this study (7,81 mM). Differently to previous 
studies and to the present research, Friedman et al. (2002) found that the best 
inhibitory  substance  against  C.  jejuni  was  carvacrol  instead  of  eugenol  and 
thymol.  Indeed,  the  concentration  of  carvacrol  that  killed  50%  of  bacterium 
during 60 minutes of incubation was 0.7 mM, whereas eugenol was 1.3 mM and 
thymol was 1.6 mM. The comparison between the results obtained in this study 
and the one from other researchers is difficult because flavors are very complex 
mixtures of compounds with different structures and chemical composition (Lee 
et al., 2004). Furthermore, they are poorly soluble in water and their antibacterial 
activity has been tested with different methods and techniques such as type and 
quality of emulsifier and strains and number of cells of micro-organisms tested 
(Zaika, L. L. 1988, Lahlou,  2004, Peñalver et a., 2005). 
Organic acids resulted less effective than flavors in terms of molar concentration, 
but caprylic acid showed in broth and agar the same MIC obtained for carvacrol 
and thymol by broth dilution method against C. perfringens ATCC 13124; even 
benzoic and heptanoic acids showed the same MIC of salycilaldehyde and thymol, 
and  propionic  acid  obtained  the  same  MIC  of  vanillin  against  C.  jejuni.  Ten 
among the tested acids permitted a visible C. jejuni growth on agar even at the 
greatest concentration of each acid. A recent study indicated also that fumaric or 
malic acids (10 to 50 mM), lactic acid (20-50 mM) and succinic acid (30-50 mM) 
or mixtures of all of them at 10-40 mM added to media could stimulate the growth 
of Campylobacter spp, whereas citric acid was not able to stimulate the growth of 
three of six Campylobacter spp isolates showing that those isolates could not use 
citric acid as a metabolite (Hinton, 2006). In our study fumaric, lactic, succinic, 
and citric acids permitted visible C. jejuni growth on agar even at the greatest 
concentration of each compound, whereas malic acid stopped its growth at 250 
mM after 24h and 48h. 
The mode of action of organic acids is primarly associated to the fact that the 
undissociated organic acids can penetrate the bacteria cell wall and disrupt the 
normal  physiology  of  bacteria  pH  sensitive  (Gauthier,  2002).  Lambert  and 
Stratford (1999) described that after the undissociated acid passed through the 
bacterial cell wall, it dissociates, because of the inner cell pH, releasing H
+ and   47
anion COO
-. The internal pH decreases and because pH sensitive bacteria do not 
tolerate  large  variation  of  cytoplasmic  pH  values,  a  specific  mechanism  (H
+-
ATPase pump) acts to bring the pH inside the bacteria to a physiological level. 
This phenomenon requires energy and it can stop the growth of the bacteria or 
even kills them. A lower internal pH involves others mechanisms: inhibition of 
glycolysis,  prevention  of  active  transport,  interference  with  signal  transduction 
(Gauthier, 2002; Piva, 2000). The anionic part of the acid is trapped inside the 
bacteria  because  it  can  not  diffuse  freely  through  the  cell  wall,  and  its 
accumulation becomes toxic (Roe et al., 1998). Different bacteria show different 
levels of sensitivity to different organic acids under specific circumstances.  
In conclusion, the results obtained in this study suggest that Clostridia were more 
sensitive than C. jejuni to antimicrobial effect of tested molecules; organic acids 
resulted less effective than flavors against tested bacteria and some of these could 
even stimulate the growth of C. jejuni. Further studies are needed to choose right 
combination of substances to reduce carcass contamination at slaughterhouse and 
increase meat safety.   48
Table  3.1:  Experimental  MIC  values  of  all  the  tested  substances  against  10
4 
CFU/mL of C. perfringens ATCC 13124, C. perfringens FI, and C. jejuni ATCC 
33291 after 48 h of incubation. The values are expressed as mM/L. (n =3) 
  C. perfringens 
ATCC 13124 
C. perfringens  
FI 
C. jejuni ATCC 
33291 
Carvacrol  15.63  3.91  7.81 
Eugenol  3.91  3.91  1.95 
Salicylaldehyde  31.25  31.25  31.25 
Thymol  15.63  3.91  31.25 
Vanillin  15.63  62.50  62.50 
Acetic acid  NA
b  ND
c  NA
b 
a-chetoglutaric acid  NA
b  ND
c  ND
c 
Benzoic acid  31.25  ND
c  31.25 
Caprylic acid  7.81  ND
c  62.50 
Citric acid  62.50  ND
c  NA
b 
Formic acid 
bNA  ND
c  NA
b 
Fumaric acid  500  ND
c  NA
b 
D-Gluconic acid  500  ND
c  NA
b 
Heptanoic acid  7.81  ND
c  31.25 
Iso-butyric acid  500  ND
c  NA
b 
Lactic acid  1000  ND
c  NA
b 
DL-Malic acid  125  ND
c  250 
Propionic acid  NA
b  ND
c  62.50 
Sorbic acid  31.25  ND
c  500 
Succinic acid  500  ND
c  NA
b 
Tartaric acid  1000  ND
c  NA
b 
n-Valeric acid  125  ND
c  NA
b 
bNA = not available 
cND = not determined. 
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3.2.  DETERMINATION  OF  THE  MINIMAL  INIBITORY 
CONCENTRATION  OF  CITRIC  ACID  AND/OR  THYMOL 
AGAINST  STRAINS  OF  SALMONELLA  ENTERITIDIS, 
ESCHERICHIA  COLI  O157:H7  AND  CLOSTRIIDUM 
PERFRINGENS  AT  6,  12  AND  24  H  OF  INCUBATION,  BY 
GROWTH  AND  ABSORBANCE  MISURAMENT  IN 
MICROTITER PLATES. 
 
 
3.2.1. Aim of the study 
 
The  purpose  of  the  study  was  the  determination  of  the  Minimal  Inhibitory 
Concentration (MIC) of citric acid and thymol, alone or in combination, against 
Salmonella  enteritidis,  Escherichia  coli  O157:H7,  and  Clostriidum  perfringens 
and the individuation of an additive, synergistic or antagonist effect, when tested 
in combination. 
 
3.2.2. Material and methods 
 
Bacterial strains and growth conditions 
Bacterial strains object of the study were Salmonella enteritidis 3502, Escherichia 
coli  O157:  H7  ATCC  35150  and  Clostridium  perfringens  ATCC13214. 
Salmonella strain, isolated from salami, was kindly provided from Dr. John B. 
Luchansky, USDA, Microbial and Food Safety Research Unity, Wyndmoor, PA, 
USA),  stored  in  Brain  Heart  Infusion  agar  plates  (BHI,  Oxoid,  Unipath  Ltd, 
Basingstoke,  Hampshire,  RG24  OPW),  while  E.  coli  and  C.  perfringens  were 
bought from American Type Culture Collection (ATCC, University Boulevard, 
Manassas, VA, USA). S. enteritidis was revitalized by transferring a colony from 
the  agar  plate  to  a  tube  containing  BHI  broth  by  mean  of  a  sterile  loop,  and 
incubating  the  so-obtained  culture  at  37°C  for  24h.  After  the  incubation  the   50
Salmonella stock culture was stored at -20°C. After E. coli and C. perfringens 
were revitalized according to manufacturer instruction, the master strains were 
stored at –20°C in BHI broth, and at room temperature in Cooked Meat (CM 
broth, Difco Laboratories, Division of Becton Dickinson and Company, Sparks, 
MD, USA), respectively. S. enteritidis and E. coli working seeds were obtained by 
inoculating  100  L of each stock culture in 10 mL of BHI broth incubating all at 
37°C for 24h through two subsequent incubations; C. perfringens working seed 
was obtained by inoculating  100  L of the stock culture in 10 mL of Reinforced 
Clostridial Medium broth (RCM, Oxoid, Unipath Ltd, Basingstoke, Hampshire, 
RG24 OPW) and incubating all in anerobic conditions at 37°C for 24h through 
two subsequent incubations.  
Chemicals 
Thymol  and  citric  acid  were  purchased  by  Sigma-Aldrich  Chemie  Gmbh, 
Steinheim, Germany. The molecules were diluted in BHI for S. enteritidis and E. 
coli and in RCM broth for C. perfringens tests as described below.  
Broth dilutions method and MIC determination in microtiter plates 
Citric acid was diluted in BHI or RCM broth in order to obtain 500 mM solutions 
(stock  solutions);  thymol  was  dissolved  in  BHI  and  RCM  with  5%  (vol/vol) 
ethanol to a final concentration of 62.5 mM or 23.36 mM. All the stock solutions 
were  adjusted  to  pH  6.5,  and  sterilized  by  filtration  (pore  diameter  0.22  mm). 
Serial dilutions of each stock solutions were made in BHI or RCM broth with pH 
6.5 to reach final concentrations in the microtiter plates of: 250, 125, 62.5, 31.25, 
15.63 mM for citric acid; 1.46, 0.98, 0.73, 0.49, 0.37 mM for thymol; citric acid 
and thymol combinations at same concentrations (except citric acid 250 mM); 
S. enteritidis, E. coli and C. perfringens inhibition trials were performed on 10
4 
CFU/well:  each  well  (96-  wells  microtiter  plates)  was  filled  with  100  ml  of 
bacterial  inoculum  (10
5  CFU/ml)  and  with  100  ml  of  the  citric  acid/  thymol 
solution. The positive control reference well was inoculated in the same way with 
100  ml  of  a  10
5  CFU/ml  culture  and  100  ml  of  broth  (pH  =  6.5)  without  the 
addition of any substance. Each substance was tested in duplicate. S. enteritidis 
and E. coli plates were incubated at 37 °C in aerobiosis, C. perfringens plate was 
incubated at the same temperature but in anaerobic conditions.   51
The turbidity of cultures was used as index of bacterial growth and optical density 
(OD) was measured after 6, 12 and 24h of incubation using a spectrophotometer 
(Tecan Spectra Classic, Tecan Group Ltd, Switzerland) at lambda (l) = 630 nm.  
The MIC was defined as the lowest concentration of molecule that completely 
inhibited  the  growth  of  the  organism  as  detected  with  the  absorbance 
measurement. To evaluate the effect of the combinations, the fractional inhibitory 
concentration (FIC index) was calculated for each substance in each combination 
(Ohran et al., 2005). The following formulas were used to calculate the FIC index: 
SFIC = FIC A + FIC B, were FIC A was the ratio between the MIC of substance 
A in combination and MIC of substance A alone and FIC B was the ratio between 
the  MIC  of  the  substance  B  in  combination  and  MIC  of  substance  B  alone. 
Synergy was defined as a SFIC £0.5, an additive effect was defined when the 
SFIC  is  >0.5  to  <2,  Indifference  was  defined  as  a  SFIC  ³  2  but  <  4  and 
antagonism was defined as a SFIC ³ 4.  
Statistical analyses and interpretation of results 
For each bacterial strain, OD data were analyzed for each tested compound by 
One-way ANOVA; the differences among means of groups were obtained using 
Newman-Keuls t-test based on the variances derived from ANOVA (GraphPad 
Prism  4.0;  GraphPad  Software,  San  Diego,  CA,  USA).  Differences  were 
considered statistically significant at P<0.05. 
 
3.2.3. Results and Discussion 
 
S. enteritidis growth after 6 h of incubation was inhibited by citric acid at 250 mM 
and  by  citric  acid  and  thymol  in  combination  at  15.63  and  1.46,  respectively, 
whereas thymol at 1.46 mM did not decrease optical density values. The MIC of 
citric acid and thymol after 12 h and 24 h alone was not determined because the 
highest  concentrations  of  the  two  molecules  were  not  effective  in  inhibiting 
Salmonella growth, while the MIC of the combination at 12 h was 31.25 mM and 
0.95 mM, for citric acid and thymol, respectively, and  62.5 mM and 1.46 mM at 
24 h , although the  combination of 31.25 mM of citric acid and 1.46 mM of 
thymol already reduced growth by 80% when compared to positive control. The   52
latter combination ( 15.63 mM of citric acid and 0.37 mM of thymol) reduced S. 
enteritidis growth of  30% when compared to control (Fig. 3.a). 
The  MIC  of    E.  coli  after  6  h  were  the  same  observed  for  S.  enteritidis; 
nevertheless, after 12 h, E. coli resulted to be more sensitive than Salmonella to 
the action of citric acid and thymol individually tested, being inhibited by citric 
acid at 250 mM, and by thymol at 1.46 mM, while the MIC of the two molecules 
combined together was the same of the one observed in Salmonella. At 24 h citric 
acid and thymol were not able to inhibit E. coli growth when individually tested, 
but in combination the MIC values were 31.25 mM and 1.46 mM, for citric acid 
and thymol, respectively; similarly to what observed in Salmonella results,  the 
combination of 15.63 mM of citric acid and 1.46 mM of thymol reduced growth 
by 80% (Fig. 3.b). 
C. perfringens growth was measured only after 12 and 24 h. After 12 h it resulted 
more sensitive than E. coli and S. enteritidis to the antibacterial effect of both 
citric acid and thymol: the MIC values were 3.9 mM and 1.46 mM of citric acid 
and thymol, respectively, and 3.9 mM and 0.37 mM when tested in combination. 
After 24 h the MIC values were the same of  that at 12 h with the exception of 
thymol alone which was 3.9 mM instead of 1.46 as observed at 12 h (Fig 3.c). 
These findings suggest that C. perfringens is more sensitive than S. enteritidis and 
E. coli to the action of organic acids and flavors, thus confirming observations  of 
the  previous  study  on  the  inhibitory  power  of  such  molecules  against  Gram-
positive and Gram-negative bacteria. In the experiment with C. perfringens an 
additive effect between citric acid and thymol was found, as it is reflected by the 
FIC index (0.7 and 0.6 at 12 and 24 h, respectively); nevertheless the combination 
of the two molecules allowed to reach the MIC by lowering their inclusion rate in 
the medium of 50 % and 90% for citric acid and thymol, respectively (Tab. 3.2.) 
when  compared  to  citric  acid  and  thymol  alone.    In  S.  enteritidis  and  E.  coli 
experiments  the  synergistic  effect  is  present,  although  FIC  index  were  not 
calculated because the MIC of citric acid and thymol for S. enteritidis and E. coli 
were not detectable at the highest concentrations tested. Citric acid and thymol 
combined  in  the  culture  media  allowed  to  reach  a  MIC  whereas  the  two 
substances  tested  alone  did  not.  Citric  acid  and  thymol  concentrations   53
corresponding to MIC values tested in combination for E. coli and S. enteritidis, 
i.e. 15.63 mM of citric acid and 1.46 mM of thymol, and the dose with 3.9 mM of 
citric acid and 0.37 mM of thymol for C. perfringens, had the same citric acid to 
thymol ratio (about 10:1) which suggests that citric acid and thymol act in synergy 
in determining their antimicrobial effect against pathogen strains when used in 
such a ratio.  
These results are of great interest to animal husbandry, where, for many years, 
antibiotic  growth  promoters  (AGP)  helped  to  improve  animal  performance, 
exerting  a  control  on  intestinal  microflora  and  reducing  the  development  of 
pathogens, being E. coli and Salmonella the maior causes of mortality in piglets at 
weaning. The possible development of antibiotic resistant bacteria led the AGP 
ban in Europe as of January 1
st 2006. This ban increased the interest in finding 
natural  alternative  to  growth  promoters,  such  as  flavors  and  organic  acids. 
Partanen and Mroz (1999) extensively reviewed organic acids positive effect on 
piglets performance at weaning, especially citric acid which improved feed to gain 
ratio. Flavors are studied because of their antimicrobial and antitoxin properties 
(Dorman  and  Dean,  2000;  Burt,  2004),  for  their  effect  in  stimulating  enzyme 
activity or for immunomodulatory properties (Middleton and Kandaswami 1992; 
Azumiet al., 1997; Platel and Srinivasan, 2000, Manzanilla et al., 2004). Even if 
many  researchers  investigated  on  such  alternatives,  few  studied  interactions 
between different classes of molecules and the possible synergy both in vitro and 
in vivo (Delaquis et  al., 2002; Manzanilla et a., 2004) in order to have better 
performance. 
In  the  present  study  the  MIC  of  thymol  individually  tested  on  E.  Coli  and 
Salmonella was an unknown value above 1.46 mM (0.2 µg/mL); when thymol is 
used  in  combination  with  an  organic  acid,  such  as  citric  acid,  the  MIC  value 
decrease to 0.95 after 12 h of incubation, which can be converted to 0.13 µg/mL. 
Citric acid, at the same way, had a MIC value of 250 mM when individually 
tested (48 µg/mL), whereas it had 31.25 mM (6 µg/mL) after 12 h of incubation 
combined with thymol. The antibiotic growth promoters, such as Tylosin, were 
used as feed additive from 44 to 110 µg/mL, depending on the type of molecule 
and on the stage of production (Si et al., 2006). As the MIC values of this study   54
were lower than the concentration of AGP in swine production ( 44-110 µg/mL vs 
6.1  µg/mL)  it  can  be  thought  that  they  could  be  valid  alternative  for  dietary 
antibiotics to be included at lower levels.  
 
 
Tab.  3.2.  Synergistic  antibacterial  effect  of  citric  acid  and  thymol  against  S. 
enteritidis,  E.  coli  O:157  and  C.  perfringens  after  6,  12  and  24-hours  of 
incubation. The MIC concentration of citric acid and thymol used in combination 
are expressed as per cent of MIC concentration of acid or thymol individually 
tested. 
h 
MIC 
Citric acid 
MIC 
Thymol 
MIC 
Citric acid + Thymol 
Citric acid 
(%) 
Thymol 
(%) 
FIC 
 
             
      S. enteritidis       
6  250  ND  15.63 + 1.46  6.2  100
a  - 
12  ND  ND  31.25 + 0.95  12.5
a  65
a  - 
24  ND  ND  62.56 + 1.46  25
a  100
a  - 
             
      E. coli       
6  250  ND  15.63 + 1.46  6.2  100
a  - 
12  250  1.46  31.25 + 0.95  12.5  65  0.8 
24  ND  ND  31.25 + 1.46  12.5
a  100
a  - 
             
      C. perfringens       
12  7.8  1.46  3.9 + 0.37  50  25.3  0.7 
24  7.8  3.9  3.9 + 0.37  50  9.5  0.6 
a where the MIC was not detectable (ND) it was considered the highest concentration 
tested   55
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Fig. 3.a: Absorbance (l= 630 nm) values of S. enteritidis growth after 6, 12, and 24 h of 
incubation. Column bars indicate mean ± SD. Each column is the mean of two values. T= 
thymol; C= citric acid  56
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E.coli 24 h
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Fig. 3.b: Absorbance (l= 630 nm) values of E. coli O157: H7 growth after 6, 12, and 24 
h of incubation. Column bars indicate mean ± SD. Each column is the mean of two 
values. T= thymol; C= citric acid  57
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C.perfringens 24 h
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Fig. 3.c: Absorbance (l= 630 nm) values of C. perfringens  growth after  12 and 24 h of 
incubation. Column bars indicate mean ± SD. Each column is the mean of two values. T= 
thymol; C= citric acid.  58
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4.1.  ROLE  OF  CITRIC  ACID  AND  THYMOL  IN  IN  VITRO  
SWINE FERMENTATION 
 
 
4.1.1. Aim of the study 
 
Purpose of this part of the study was to screen the role of citric acid and thymol in 
modulating the intestinal microflora of pigs in an in vitro fermentation system 
(batch-culture  techniques),  which  simulate  the  intestinal  environment  and 
microflora. A two step procedure was applied: 1) digestion of the feed through 
enzymatic reactions; 2) fermentation of the digested diet with intestinal content 
and substances under investigations. It has been studied the effect of citric acid 
and thymol on both small intestinal and cecal parameters through two subsequent 
studies. 
 
4.1.2. Materials and methods 
 
Digestion. 
A standard diet for weaner pigs (Table 4.1) was digested in vitro to simulate ileal 
digestion as described by Verveake et al. (1989). This was a stepwise procedure 
with an incubation of feed (25 g; particle size < 1 mm) in 500 mL of pepsin 
solution (0.2% pepsin w/v, HCl 0.075 N; P7000 from porcine gastric mucosa; 
Sigma Chemical, St. Louis, MO, USA) in a shaking waterbath at 37°C for 4 h. At 
the end of the 4h incubation, the solution was adjusted to pH 7.5 with NaOH 0.1 
N. In the second step 500 mL of a pancreatin-NaHCO3 mixture solution (10g/L 
w/v pancreatin of 1M NaHCO3; P1500, from porcine pancreas; Sigma Chemical, 
St. Louis, MO, USA) was added and the mixture was reincubated for 4 h at 37°C 
to simulate pancreatic digestion. Composition of the phosphate buffer solution 
was as follows: 26.2 mM Na2HPO4, 46.7 mM NaHCO3, 3.3 mM NaCl, 3.1 mM 
KCl, 1.3 mM MgCl2, 0.7 mM  CaCl2 (Martillotti et al., 1987). 
After enzymatic digestion, the preparation was centrifuged (3,000 ´ g, 10 min., 4 
°C), washed twice with distilled water, recentrifuged (3,000 ´ g, 5 min., 4 C°),   60
and  dried  at  60°C  overnight.  Chemical  analyses  of  the  diet  before  and  after 
digestion are reported in Table 4.2. The digested diet was used as the substrate in 
the in vitro fermentation study. 
Fermentation.  
Within 20 min after slaughter of pigs (six animals, 10 months old, live weight 
approximately 160 kg) small intestine or cecal contents were collected and kept in 
a sealed nylon bag at 37°C during transfer to the laboratory. Small intestine and 
cecal contents were then diluted with buffer (ratio 1:10 and 1:3, respectively) and 
filtered  through  six  layers  of  cheese  cloth.  The  filtered  liquid  was  used  as 
inoculum.  The  buffer  composition  (McDougall  1948)  was  as  follows:  9.8  g 
NaHCO3 + 0.57 g KCl + 0.079 g CaCl2·6H2O + 9.3 g Na2HPO4·12H2O + 0.67 g 
NaCl  +  0.12  g  MgSO4·7H2O  in  1  L  of  distilled  water.  Buffer  pH  was  then 
adjusted to pH 6.7 by adding 3N HCl. The buffer solution was kept at 37°C and 
flushed with CO2 for 20 minutes before use. The inoculum was dispensed into 
five 10 mL glass syringes (5 mL of inoculum in each syringe) and five 50 mL 
vessels (previously  flushed with CO2, 15 mL  of inoculum in each vessel) per 
treatment, containing 20 and 100 mg of predigested diet, respectively (Piva et al. 
1996). Syringes and vessels were sealed and incubated at 37°C for 24 h. For small 
intestine fermentation the diet was digested until the first step of the digestion 
procedure in order to obtain the gastric digestion products only, while the diet for 
cecal fermentation underwent also the pancreatic digestion step.  
Six dietary treatments were investigated: control diet (CTR), or control diet added 
with a solution of citric acid (pH 6.7) at 1875 ppm (CA), of thymol (pH 6.7)  at 
125 ppm (TY), citric acid and thymol at 750 and 50 ppm, respectively (CT1), 
citric acid and thymol at 1875 and 125 ppm, respectively (CT2), and citric acid 
and thymol at 3000 and 200 ppm, respectively (CT3). Citric acid and thymol were 
purchased from Sigma-Aldrich (Chemie Gmbh, Steinheim, Germany). 
Gas production was measured as described by Menke et al. (1979), using 10 mL 
glass syringes and recording the cumulative volume of gas produced every 30 
min. Samples of fermentation fluid were collected from each vessel at time 0, 4, 8 
and  24  h  after  incubation  in  a  shaking  water  bath  for  ammonia  analysis;  pH, 
microbial counts and SCFA were determined at the end of the fermentation.   61
Chemical analyses of feed and fermentation fluid.  
Analyses of the diets (crude protein, crude fiber, ether extract, ash, and starch) 
were performed according to AOAC standard methods (AOAC, 2000; Method 
954.01 for crude protein, Method 962.09 for crude fiber, Method 920.39 for ether 
extract, Method 942.05 for ash, Method 920.40 for starch) . 
Ammonia in fermentation fluid and intestinal chymus was measured as described 
by Searcy et al. (1967). 
The short chain fatty acids (SCFA) in fermentation fluid were analysed by gas 
chromatography  (Varian  3400,  Varian  Analytical  Instruments,  Sunyvale,  CA 
94089, USA; Carbopack B-DA/4% CW 2M, 80/120, packed column; Supelco, 
Sigma  Aldrich  s.r.l.,  20151  Milano,  Italy).  The  fermentation  liquid  was 
centrifuged (3,000 ´ g, 15 min.) and 2 mL of the supernatant were added with 
pivalic acid as an internal standard (Fussel and McCalley, 1987) prior to injection.  
Bacterial counts. 
Viable  counts  of  bacteria  in    fermentation  samples  were  measured  by  plating 
serial  10-fold  dilutions  onto  Rogosa  agar  plates  (CM  627  B,  OXOID, 
Bansingstoke,  UK)  for  Lactic  Acid  Bacteria  (LAB),  Tryptose  Sulphite 
Cycloserine Agar (TSC, CM 587 B, OXOID, Bansingstoke, UK) for Clostridia, 
and  Violet  Red  Bile  Agar  (VRBA,  DIFCO,  Becton,  Dickinson  and  Company, 
Sparks, Maryland, USA) for coliforms according to the manufacturer conditions. 
There were three plate-replicates per treatment. Rogosa and TSC agar plates were 
incubated for 48 h at 37°C under anaerobic conditions. VRBA agar plates were 
incubated for 24 h at 37°C under aerobic conditions. 
Statistical analyses. 
A modified Gompertz bacterial growth model (Zwietering et al. 1992) was used to 
fit gas production data. This model assumes that substrate levels limit growth in a 
logarithmic relationship (Schofield et al. 1994) as follows: 
V = VF exp { - exp [1 + (mme/VF)(l - t)]} 
where  symbols  have  the  meanings  assigned  by  Zwietering  et  al.  (1990):  V  = 
volume of gas produced at time t, t = fermentation time, VF = maximum volume 
of gas produced, mm = maximum rate of gas production, which occurs at the point   62
of inflection of the gas curve and l = the lag time, as the time-axis intercept of a 
tangent line at the point of inflection. 
The duration of the exponential phase was calculated from the parameters of the 
modified Gompertz equation, as suggested by Zwietering et al. (1992) with the 
following: 
exponential phase (h) = VF/(mme){1 - ln[(3 -  5 )/2]}. 
Curve fitting was performed using the program GraphPad Prism 4.0 (GraphPad 
Software,  San  Diego,  CA,  USA).  Total  gas  production,  maximum  rate  of  gas 
production, duration of the exponential phase, ammonia, pH, bacterial counts, and  
SCFA  data  were  analyzed  by  ANOVA  using  GraphPad  Prism  4.0  (GraphPad 
Software, San Diego, CA, USA) in a completely randomized design. Each syringe 
and vessel formed the experimental unit. The differences among means of groups 
were  analyzed  using  the  Newmann-Keuls  test.  Differences  were  considered 
statistically significant at P< 0.05.   63
 
Table 4.1: diet composition 
Ingredients
a  % 
Barley  30 
Wheat  22 
Milk whey   20 
Yogurt   5 
Proteic potatoe  4.2 
Gluten  4.17 
Soybean oil  3.5 
Yeast molasses  3.3 
Lactose  3.3 
Coconut oil  2.5 
Lys-HCl  0.6 
Vitamins and mineral premix
1  0.4 
Sweetener  0.3 
NaCl  0.3 
Met  0.17 
Tre  0.16 
Phytase  0.1 
DE kcal/kg  3412 
ME kcal/kg  3257 
NE kcal/kg  2363 
a as fed 
1Supplying per Kg: Vit. A: 16,000 IU; Vit. D3: 2,200 IU; Vit. E: 45 mg; Vit. B1: 1.8 mg; 
Vit. B2: 5.5 mg; Vit. B6: 3 mg; Vit. B12: 0.04 mg; Vit. PP: 25 mg; Vit. K3: 1.4 mg; 
Choline: 185 mg; Fe: 170 mg; Cu: 160 mg; Zn: 140 mg; Mn: 85 mg; I: 1 mg; Se: 0.3 mg; 
Co: 1 mg.   64
Table 4.2: diet chemical analysis before digestion and nutrients digestibility after 
gastric and pancreatic in vitro digestion  
Nutrients 
 (% d.m.) 
Before  
digestion 
Digestibility (%) 
gastric digestion 
Digestibility (%) 
pancreatic 
digestion 
Crude protein  17.9   73  88 
Ether extract  7.5   50  ND 
Crude Fiber  3.2  50  ND 
Crude Ash  4.9  74  ND 
Starch   44.6  30  87 
ND = not determined 
 
4.1.3. Results and discussions 
 
Small Intestine Fermentation. 
Gas  production  curves  were  accurately  described  by  the  modified  Gompertz 
model (r
2 = 0.89). 
Gompertz growth model showed that compared to control the blend of citric acid 
and thymol at 1875 and 125 ppm (CT2) and citric acid and thymol at 3000 and 
200 ppm (CT3), significantly reduced gas production by 95% for both treatments 
(P<0.01). Citric acid alone (CA) tended to reduce the maximum volume of gas 
produced by 29%. (Table 4.3). 
Maximum rate of gas production did not exhibit any statistical difference.(Table 
4.3). 
The duration of the exponential phase was significantly reduced by CT2 and CT3 
(-85.2%  and  -70.5%,  respectively,  P<0.01).  CA,  thymol  alone  (TY),  and  CT1 
lowered the duration of the exponential phase (-31%; -27%; -25%, respectively) 
without reaching significant P values. (Table 4.3). 
Gas  production  data  showed  that  citric  acid  and  thymol  may  inhibit  small 
intestinal bacterial activity when used in combination: CT2 and CT3 were able to 
determine  a  significant  reduction  of  the  microflora  activity  reflected  by  the 
volume  of  gas  produced,  which  indicates  a  lower  bacterial  metabolism  and  a 
lower  duration  of  the  corresponding  exponential  growth.  It  is  noteworthy  that   65
when the same concentrations of citric acid and thymol of CT2 were used alone, 
i.e. CA and TY treatments, they did not have the same effects on small intestinal 
microflora, thus demonstrating a synergystic effect of such molecules. CT3 had 
the  same  attitude  toward  intestinal  microflora  of  CT2  treatment  even  if  the 
concentration of citric acid and thymol was higher than the one present in the CT2 
suggesting that there was no dose-related effect.  
Ammonia concentration was measured in the fermentation fluid after 4, 8 and 24h 
from the beginning of the experiment. (Table 4.4). At 4h ammonia concentration 
in CT3 vessels was significantly reduced when compared to citric acid and thymol 
treatment alone  (-31%  for both CA and TY, P<0.05) but it was not  modified 
relative to the control. After 8h of fermentation, no changes occurred in ammonia 
production. After 24h of fermentation, ammonia concentration was reduced by all 
treatments compared to control (-19.9%, -39.5%, -27.3%, -46.4%, and -48.7% for 
CA,  TY,  CT1,  CT2,  and  CT3,  respectively;  P<0.01).  Every  treatment  was 
successful  in  controlling  ammonia  throughout  the  24h  study  even  if  the  most 
probable cause of ammonia reduction was thymol, as it reduced by itself  up to 
39.5% of ammonia when compared to control. Again, CT2 and CT3 ammonia 
reduction were not significantly different each other, as previously described for 
gas parameters, thus confirming no dose-response effect. 
Measurements of fermentation fluid pH from each treatment were assessed at the 
end of the experiment without showing statistical differences (Table 4.4).  
No Clostridia were found after 48h of incubation. Thymol alone and combinations 
of  citric  acid  and  thymol  at  the  highest  concentrations  significantly  decreased 
coliforms  counts  (-0.7  Logs,  0.5  Logs,  and  -1  Log,  for  TY,  CT2,  and  CT3, 
respectively; P<0.01) when compared to control. Lactic acid bacteria (LAB) were 
not modified by  any treatment but CT3 (citric  acid and thymol at the  highest 
concentration), which significantly lowered counts by 3 Logs when compared to 
control. The ratio coliforms/LAB was significantly higher for CT3 treatment than 
for  the  control  (1.4  vs  2.1,  respectively,  P<0.05).(Table  4.5).  These  findings 
suggest  that  thymol  and  citric  acid  at  the  highest  concentrations  may  have  a 
bactericidal effect on both coliforms and LAB,  as it can be confirmed by results 
on gas and ammonia production. Furthermore, it seems that the inhibitory effect   66
on  coliforms  can  be  related  to  thymol  rather  than  to  citric  acid  as  it  may  be 
suggested by ammonia concentrations. It can be observed that thymol can act on 
proteolitic bacteria and on coliforms exerting its antibacterial effect on both. The 
highest  concentration  used  of  the  blend  of  citric  acid  and  thymol  shifted  the 
microbial balance toward coliforms probably because of the lower resistance of 
Gram-positive  bacteria  than  Gram-negative  to  flavors  antimicrobial  properties 
(Nikaido and Varra, 1985; Russel et al., 1991; Krieg, 2001; Lis-Balchin, 2003). 
SCFA  concentration  (Table  4.6)  was  significantly  lower  in  thymol  (TY) 
containing  vessels  when  compared  to  citric  acid  (CA)  and  to  CT2  vessels 
(P<0.01), but it was not different from the control (Table 6). Acetic acid was 
increased by citric acid (CA), and CT1 (+38% and +44%, respectively, P<0.01) 
when  compared  to  control.  Propionic  acid  and  iso-butyric  acid  concentrations, 
when compared to control, were decreased by every treatment: -38%, -85%, -
61%,  -84%,  and  -87%,  for  CA,  TY,  CT1,  CT2,  and  CT3,  respectively,  for 
propionic acid (P<0.0001); -50%, -60%, -38%, -53%, and 62%, for , TY, CT1, 
CT2, and CT3, respectively, for iso-butyric acid (P<0.0001). Nor-butyric acid was 
significantly decreased by all the treatments (-39%, -91.4%, -40%, -92%, -95% 
for CA, TY, CT1, CT2, and CT3, respectively, P<0.0001), as well as iso-valeric 
acid, which was present at very small concentrations and it was absent in thymol 
and  CT2  treatments.  Nor-valeric  acid  was  not  detected  in  all  the  treatments 
whereas lactic acid was found only in CT2 and CT3 treatments.  
SCFA data confirmed the findings of the previous results, i.e. that is thymol to 
formerly  influence  the  trend  of  fermentation  pattern  in  small  intestine;  it  is 
noteworthy that only starting at 125 ppm it can exert its antibacterial action, alone 
or in combination with citric acid, and that higher concentrations of thymol did 
not influence data in a significantly different way. The trend of the decrease of 
butyric acid in all treatments is comparable to the decrease found in ammonia 
after 24 h; this can be explained by the fact that butyrate producing bacteria are 
limited to few genera, such as Clostridium spp, Butyrivibrio spp, Eubacterium 
spp,  Fusobacterium  spp,  the  former  producing  large  amounts  of  butyrate  as 
fermentation product (Holdeman et al., 1977); furthermore iso-butyric  and iso-
valeric acid are formed from the deamination of valine and leucine (Van Soest,   67
1982)  and  are  indicative  of  the  extent  of  protein  catabolism.  Although  in  this 
study Clostridia were not found in any treatment, because they were under the 
detection limit, it can be supposed that thymol has been able to control proteolysis 
during  the  24h  of  fermentation  controlling  proteolitic  bacteria,  as  indesirable 
microflora. Propionic acid was decreased by every treatment, but, again, thymol 
led the extent of this process; the molar ratio C2/C3 was appreciably increased by 
thymol alone and by CT2 and CT3 compared to control (3.14, 19.22, 35.19, 33.01 
for CTR, TY, CT2, and CT3, respectively; P<0.0001). Being propionic and acetic 
acid  final  metabolic  compounds  of  fermentation  by  Propionibacteria  and 
cellulolytic bacteria, respectively, the increase of C2/C3 ratio has been probably 
caused  by  the  inhibition  of  Propionibacteria  and  sugar  fermenters  coliforms, 
determining  a  consequent  selection  of  a  cellulolytic  flora  during  the  24h  of 
fermentation.    68
Table 4.3: Modified Gompertz equation fitted to gas production data from the 24 
h in vitro incubation of swine small intestine inoculum* 
Treatment  VF  µm  Log phase 
CTR  7.60 ± 1.84
 b  1.10 ± 0.48  6.77 ± 1.89 
b 
CA  5.38 ± 2.29 
b  1.08 ± 0.29  4.66 ± 1.43 
b 
TY  8.03 ± 1.55 
b  1.54 ± 0.39  4.96 ± 0.35 
b 
CT1  6.91 ± 1.54 
b  1.30 ± 0.52  5.09 ± 1.21 
b 
CT2  0.40 ± 0.004 
a  2.66 ± 3.31  1.00 ± 1.34 
a 
CT3  0.04 ± 0.001
 a  1.22 ± 1.50  2.01 ± 1.68 
a 
*Values means± SD of five syringes for each diet tested. Values within the same column 
with different superscripts are significantly different (P < 0.05). CTR= basal diet; CA 
=basal diet with  citric acid at 1875 ppm; TY = basal diet with thymol at 125 ppm; CT1 
= basal diet with citric acid at 750 ppm  and thymol at 50  ppm; CT2 = basal diet with 
citric acid at 1875  ppm  and thymol at 125  ppm; CT3 = basal diet with citric acid at 
3000  ppm  and thymol at 200  ppm; VF = maximum volume of gas produced (mL); mm = 
maximum rate of gas production (mL h
–1); log phase = exponential phase (h). 
 
 
Table 4.4: Ammonia values (mmol L
–1) at 4, 8 h and ammonia and pH values at 
24 h of an in vitro incubation of swine small intestine inoculum*  
Treatment  4h  8h  24h  pH 
CTR  5.55 ± 1.31
 ab  5.87 ± 1.62  23.02 ± 1.49 
e  6.88 ± 0.04 
CA  7.27 ± 0.74 
b  4.78 ± 1.47  18.45 ± 0.56 
d  6.84 ± 0.03 
TY  7.35 ± 0.41 
b  4.77 ± 0.55  13.93 ± 1.41 
b  6.78 ± 0.07 
CT1  6.15 ± 1.39 
ab  4.43 ± 1.21  16.74 ± 0.31 
c  6.79 ± 0.02 
CT2  6.10 ± 1.08 
ab  5.03 ± 1.31  12.34 ± 1.17 
a  6.62 ± 0.08 
CT3  5.05 ± 0.24 
a  4.23 ± 0.64  11.81 ± 0.39 
a  6.56 ± 0.63 
*Values are means± SD of five vessels for each diet tested. Values within the same column 
with different superscripts are significantly different (P < 0.05).   69
 
Table 4.5: Counts of viable bacteria (log10 CFU mL
–1) at 24 h of an in vitro 
incubation of swine small intestine inoculum*  
Treatment  Coliforms  LAB  Clostridia 
CTR  8.45 ± 0.11 
b  5.90 ± 0.39 
b  ND 
CA  8.97 ± 0.47 
b  5.68 ± 0.48 
b  ND 
TY  7.71 ± 0.35 
a  5.05 ± 0.23 
b  ND 
CT1  8.36 ± 0.28 
b  5.33 ± 0.06 
b  ND 
CT2  7.87 ± 0.04 
a  4.93 ± 0.03 
b  ND 
CT3  7.39 ± 0.01 
a  2.37 ± 2.13 
a  ND 
*Values are means± SD of 3 vessels for each treatment. Values within the same column 
with  different  superscripts  are  significantly  different  (P  <  0.05).  ND  =  under  the 
detection limit   70 
 
Table 4.6. Short-chain fatty acids values (mmol L
–1) after 24 h of an in vitro incubation of swine small intestine inoculum*
 
Treatment  Acetic 
acid 
Propionic 
acid 
i-Butyric acid  n-Butyric acid  i-Valeric acid  Lactic acid  C2/C3 ratio  Total acids 
CTR  20.12 ± 0.90
a  6.41 ± 0.38
d  0.37 ± 0.05
c  2.28 ± 0.23
c  0.64 ± 0.10  ND  3.14 ± 0.12
a  29.82 ± 1.48
ab 
CA  32.57 ± 1.09
cd  3.97 ± 1.89
c  0.19 ± 0.02
a  1.38 ± 0.12
b  0.08 ± 0.05  ND  8.21 ± 0.53
a  38.19 ± 1.08
b 
TY  19.11 ± 0.66
a  0.94 ± 0.03
a  0.15 ± 0.02
a  0.19 ± 0.05
a  ND  ND  19.22 ± 2.19
b  20.12 ± 0.47
a 
CT1  27.73 ± 0.85
abc  2.50 ± 0.30
b  0.23 ± 0.03
b  1.37 ± 0.12
b  0.07 ± 0.02  ND  11.20 ± 1.38
a  32.41 ± 1.50
ab 
CT2  35.35 ± 2.43
b  1.01 ± 0.08
a  0.17 ± 0.02
a  0.18 ± 0.07
a  ND  5.10 ± 2.12  35.19 ± 2.47
c  41.89 ± 6.2
b 
CT3  25.43 ± 13.35
ab  0.84 ± 0.34
a  0.14 ± 0.02
a  0.10 ± 0.02
a  0.12 ± 0.11  6.33 ± 1.68  33.01 ± 14.24
c  33.01 ± 15.6
ab 
*Values are means± SD of five vessels for each diet tested. Values within the same column with different superscripts are significantly different (P < 
0.05). 
ND = under  the limit of detection as well as n-valeric acid  71
Cecal fermentation 
Analysis of variances of VF data was significant (P = 0.03), but the post-test failed 
to show differences among means of groups. However results suggested that citric 
acid (CA) stimulates microflora fermentation in the caecum, acting as a substrate, 
and enhancing maximum volume of gas produced by 59.5% when compared to 
control (Table 4.7). Furthermore CT1, CT2, and CT3 had the same trend of citric 
acid, increasing maximum volume of gas produced by 61.7%, 27.1%, and 31.9%, 
respectively, when compared to control, while thymol tended to have no effects 
on gas production. Analysis of variances of maximum rate of gas production data 
reflected the same tendency of results obtained from analysis of gas volume but 
the post test provided significant outputs (Table 4.7). Rate max was significantly 
increased  by  all  treatments  but  the  thymol  one,  which  was  not  effective  in 
increasing rate max (+62.5%, +40%,+52.5%,  and +45% for CA, CT1, CT2, and 
CT3, respectively, P<0.01), while the duration of the exponential phase was not 
modified by any treatment (Table 4.7). 
Ammonia concentration was significantly increased after 4 h by CT2 and CT3 by 
25%  and  40%,  respectively,  when  compared  to  control  (P<0.01);  after  8  h 
ammonia  concentration  was  significantly  reduced  by  citric  acid  (CA,  -17.9%; 
P<0.05) while it was significantly increased by CT3 (+25.6%; P<0.001) when 
compared to control; after 24 h there were no differences (Table 4.8). 
Thymol  significantly  lowered  pH  values  (6.6  vs  6.5  for  CTR  and  TY, 
respectively,  P<0.05)  whereas  citric  acid  (CA)  had  the  opposite  effect  by 
highering the pH from 6.6 to 6.7 (P<0.001) (Table 4.8).  
The  highest  concentration  of  citric  acid  and  thymol  combined  together 
significantly  lowered  coliforms  counts  by  1.4  Logs  (P  =  0.01),  whereas  it 
increased  LAB by 0.4 Logs (P<0.01), thus resulting in a lower ratio coliforms/ 
LAB  when  compared  to  control  (0.9  vs  0.6  for  CTR  and  CT3  respectively, 
P<0.0001) (Table 4.9). 
Following gas production trend, compared to control, CT2 and CT3 significantly 
increased total SCFA concentration (+29% and +64%, respectively; P<0.0001) 
(Table  4.10);  acetic  acid  was  increased  by  citric  acid  alone  and  by  the 
combination of thymol and citric acid at the two highest concentrations (+20.6%,   72
+43.3, and +91.8%, for CA, CT2, and CT3, respectively; P<0.0001); compared to 
control thymol decreased propionic acid (-10.4%, P = 0.0015), iso and nor-valeric 
acid  amounts  (-24.5%  and  -15.4%,  respectively,  P<0.05);  iso-butyric  acid 
concentration was not affected by any treatment, whereas nor-butyric acid was 
increased by CT3 when compared to control (+27.5%, P<0.0001). Lactic acid was 
not detected in any treatments. 
These  findings  suggest  that  in  caecum  interactions  between  molecules  under 
investigation and the environment are completely different from the ones in the 
small intestine. In caecum citric acid acts as a substrate for microflora, strongly 
increasing gas production from 750 to 3,000 ppm, alone or in combination with 
thymol. It is known that several bacterial strains can use citric acid (Medina de 
Figueroa et al., 2000) as an energy source: certain species of Leuconostoc are able 
to  uptake  citrate  and  to  split  it  into  oxalacetate  and  acetate,  the  former  being 
decarboxilated  to  form  pyruvate  and  subsequently  reduced  to  lactate  (Marty-
Teysset  et  al.,  1996);  furthermore,  Ln.  mesenteroides  maintains  the  inner  pH 
around  6.5-7.0  in  acidic  environment  (pH  =  4),  when  using  citric  acid  as  a 
substrate (Belguendouz et al., 1997).  
Interestingly,  despite  the  opposite  effects  on  gas  production,  after  8  h  of 
fermentation, citric acid vessels resulted in lower ammonia concentration than in 
control ones when used alone at 1875 ppm, suggesting that an effective control of 
ammonia cecal concentration may be achieved by selecting a type of microflora 
which  positively  influences  fermentation,  shifting  the  compostition  of  the 
microflora from coliforms to LAB, (ratio coliforms/ LAB, 0.9 vs 0.6 for CTR and 
CT3, respectively). As citric acid is metabolized in a very fast way, the control of 
ammonia production is limited to the first 8 h of fermentation, while it decrease at 
24 h, when data suggest that there were no differences in ammonia concentration 
among treatments. The higher concentration of ammonia in CT2 and CT3 vessels 
than  in  control  ones  is  related  to  the  higher  metabolic  microflora  activity  as 
suggested by gas parameters and SCFA concentration: the higher the volume of 
gas  produced,  the  higher  the  number  of  cells  of  anaerobic  fermentative 
microorganisms and the cellular turnover and metabolic and catabolic products 
concentration. Metabolism of hetero-fermentative LAB produces only 50% lactic   73
acid and considerable  amounts of ethanol, acetic acid and  carbon dioxide; the 
higher  number  of  LAB  found  in  CT3  treatments  caused  an  higher  acetic  acid 
concentration beside the higher production of gas. Acetic to propionic ratio was  
significantly increased by every treatment, especially by CT3 (2.9 vs 4.9, for CTR 
and CT3, respectively, P<0.001) suggesting the role of citric acid as a substrate 
for a cellulolytic and “positive” bacteria in the cecum. From this analysis it could 
be concluded that citric acid alone, or in  combination with thymol at the two 
highest  concentrations,  stimulates  the  growth  of  LAB  and  of  an  “healthy” 
microflora, as previously described by Drinan et al., (1976). 
In caecum thymol antibacterial activity seems to be not as strong as in the small 
intestine. This could be explained by the fact that despite well known thymol 
antibacterial  properties  (Burt,  2004)  there  are  several  bacteria,  among  which 
Pseudomonas strains, capable of assimilating thymol or its analogue carvacrol, 
degrading it completely by a specific metabolic pathway involving the opening of 
the hydroxilic-phenolic ring (Chamberlain and Dagley, 1968) and leading to the 
release of acetate, 2-ketobutyrate, and isobutyrate. In the large intestine there are 
10
10 to 10
11 viable cells per gram of intestinal content (Butine and Leedle, 1989), 
most  of  them  still  unidentified,  while  in  the  small  intestine  there  is  a  lower 
number  of  microorganism  (10
7-10
8  CFU/g;  Jensen  and  Jorgensen,  1994),  a 
smaller extent of which may be able to use aromatic compounds as an energy 
source, resulting in a more sensitive microflora to antibacterial substances such as 
thymol or other phenolic compounds. Furthermore thymol had an inhibiting effect 
on propionic acid production as it had in the small intestine fermentation , thus 
confirming  previous  observations  on  thymol  inhibitory  power  on  sugar-
fermentative  bacteria.  
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Table 4.7: modified Gompertz equation fitted to gas production data from the 24 
h in vitro incubation of swine cecum inoculum* 
Treatment  Vf  µm  Log phase 
CTR  4.02 ± 1.57  0.40 ± 0.09 
a  8.78 ± 2.34 
CA  6.41 ± 1.12  0.65 ± 0.09 
b  8.83 ± 2.59 
TY  3.78 ± 1.73  0.37 ± 0.08 
a  8.88 ± 2.59 
CT1  6.50 ± 0.46  0.56 ± 0.06 
b  10.06 ± 0.31 
CT2  5.12 ± 2.01  0.61 ± 0.15 
b  7.38 ± 1.54 
CT3  5.31 ± 0.71  0.58 ± 0.01 
b  8.72 ± 0.86 
*Values are means± SD of five syringes for each diet tested. Values within the same 
column with different superscripts are significantly different (P < 0.05). CTR= basal diet; 
CA =basal diet with  citric acid at 1875 ppm; TY = basal diet with thymol at 125 ppm; 
CT1 = basal diet with citric acid at 750 ppm  and thymol at 50  ppm; CT2 = basal diet 
with citric acid at 1875  ppm  and thymol at 125  ppm; CT3 = basal diet with citric acid 
at 3000  ppm  and thymol at 200  ppm; VF = maximum volume of gas produced (mL); mm 
= maximum rate of gas production (mL h
–1); log phase = exponential phase (h). 
 
Table 4.8: Ammonia values (mmol L
–1) at 4, 8 h and ammonia and pH values at 
24 h of an in vitro incubation of swine cecum inoculum* 
Treatment  4h  8h  24h  pH 
CTR  9.34 ± 1.99 
a  11.93 ± 1.37 
b  20.66 ± 1.56  6.62 ± 0.03 
b 
CA  7.79 ± 0.65 
a  9.79 ± 1.13 
a  20.13 ± 0.96  6.72 ± 0.03 
c 
TY  8.91 ± 1.47 
a  11.77 ± 1.30 
b  19.51 ± 1.92  6.54 ± 0.02 
a 
CT1  9.42 ± 1.85 
a  11.68 ± 0.91 
b  19.56 ± 1.24  6.61 ± 0.02 
b 
CT2  11.67 ± 0.98 
b  12.58 ± 0.65 
b  19.11 ± 1.30  6.57 ± 0.03 
ab 
CT3  13.07 ± 2.08 
b  14.98 ± 0.55 
c  19.08 ± 0.82  6.58 ± 0.07 
b 
*Values are means± SD of five vessels for each diet tested. Values within the same column 
with different superscripts are significantly different (P < 0.05). 
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Table 4.9: Counts of viable bacteria (log10 CFU mL
–1) at 24 h of an in vitro 
incubation of swine cecum inoculum*  
Treatment  Coliforms  LAB  Clostridia 
CTR  6.23 ± 0.004 
b  7.22 ± 0.11 
a  3.45 ± 0.21 
CA  6.67 ± 0.57 
b  7.16 ± 0.02 
a  3.75 ± 0.18 
TY  6.57 ± 0.98 
b  7.4 ± 0.14 
a  3.36 ± 0.32 
CT1  6.77 ± 0.36 
b  7.35 ± 0.13 
a  3.42 ± 0.39 
CT2  5.86 ± 0.24 
b  7.42 ± 0.03 
a  3.00 ± 0.00 
CT3  4.85 ± 0.4 
a  7.67 ± 0.01 
b  2.16 ± 1.89 
*Values are means± SD of 3 vessels for each treatment. Values within the same column 
with different  
superscripts are significantly different (P < 0.05).   76 
Table 4.10. Short-chain fatty acids values (mmol L
–1) after 24 h of an in vitro incubation of swine cecal inoculum*
 
Treatment  Acetic 
acid 
Propionic 
acid 
i-Butyric acid  n-Butyric acid  i-Valeric acid  n-Valeric acid  C2/C3 ratio  Total acids 
CTR  50.28 ± 3.18
a  17.28 ± 0.72
b  1.83 ± 0.04  5.99 ± 0.42
a  1.62 ± 0.08
d  1.36 ± 0.05
b  2.91 ± 0.13
a  78.36 ± 4.19
a 
CA  60.66 ± 3.68
b  17.76 ± 1.03
b  1.97 ± 0.04  5.84 ± 0.44
a  1.46 ± 0.13
c  1.31 ± 0.12
ab  3.41 ± 0.05
c  88.95 ± 5.40
a 
TY  52.01 ± 7.25
a  15.48 ± 2.27
a  1.75 ± 0.24  5.39 ± 0.93
a  1.22 ± 0.15
a  1.15 ± 0.15
a  3.36 ± 0.06
c  77.01 ± 10.97
a 
CT1  59.75 ± 2.55
b  18.43 ± 0.68
b  2.00 ± 0.09  6.13 ± 0.29
a  1.39 ± 0.06
bc  1.29 ± 0.05
ab  3.24 ± 0.03
b  88.99 ± 3.58
a 
CT2  72.07 ± 7.02
c  18.2 ± 1.58
b  1.86 ± 0.23  6.27 ± 0.63
a  1.27 ± 0.12
ab  1.28 ± 0.14
ab  3.96 ± 0.09
d  101.00 ± 9.61
b 
CT3  96.46 ± 4.64
d  19.73 ± 0.98
b  1.81 ± 0.17  7.64 ± 0.42
b  1.30 ± 0.08
bc  1.39 ± 0.07
b  4.89 ± 0.08
e  128.3 ± 6.18
c 
*Values are means± SD of five vessels for each diet tested. Values within the same column with different superscripts are significantly different (P < 
0.05). Lactic  acid was under the detection limit   77
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5.1.  ROLE  OF  MICROENCAPSULATED  CITRIC  ACID  AND 
THYMOL  TESTED  INDIVIDUALLY  OR  COMBINED  ON 
PRODUCTIVITY  AND  INTESTINAL  MICROFLORA  OF 
NEWLY WEANED PIGLETS 
 
 
5.1.1. Aim of the study 
 
Aim of the in vivo studies was to test the efficacy of citric acid and thymol as in 
feed  additives  alternative  to  antibiotic  growth  promoters  at  weaning.  Two 
experiments were assessed: in the first study it was evaluated the role of citric 
acid, thymol, and a combination of the two in improving piglets health status and 
productivity. Since it has been proven that organic acids loose their antimicrobial 
power passing through the acidity of the stomach, and that only a small amount of 
them can reach the lower gut, we  used microencapsulated substances to bypass 
the stomach acidity and to reach the small and large intestine. 
 
5.1.2. Materials and methods 
 
Animals, Housing and Dietary Treatments. 
Ninety-six  crossbred piglets (Landrace x Duroc) were weaned at 21 d and were 
transported  to the barns of the DIMORFIPA, Faculty of Veterinary Medicine, 
University of Bologna, for a post weaning trial 42 days long. The animals began 
the trial at the BW of 6.7 kg (SD = 0.7) and were immediatly  divided after their 
arrival  into  four  groups  (24  animals  per  group),  homogenous  for  weight  and 
gender and were housed in 16 cages corresponding  to four replicates of six pigs. 
Then piglets received the basal diet with or without (control diet) the addition of 
microencapsulated  (Vetagro  srl,  Reggio  Emilia,  Italy)  citric  acid  or  thymol  at 
1875  and  125  ppm,  respectively,  or  a  blend  of  the  two  providing  the  same 
amounts of citric acid and thymol. The treatments were: a) 0 ppm (CTR),  b) 
protected citric acid included at 5,000 ppm, providing acid at 1875 ppm (CA), c)   79
protected thymol included at 5,000 ppm, providing thymol at 125 ppm (TY) and 
d) protected blend of citric acid and thymol included at 5,000 ppm and providing 
the same amounts of the two principle of the other treatments (CT). All diets were 
formulated to provide the same amount of energy, protein, essential amino acids, 
calcium    and  phosphorus.  No  antimicrobial  agents  were  added  to  diets.  The 
composition of the base diet was changed after the first three weeks. Feed and 
water were provided ad libitum. Composition and estimated chemical analyses of 
the experimental diets are reported in Table 5.1 and Table 5.2, respectively. 
Experimental  Procedure and Sampling 
Body weight was recorded individually at the beginning of the trial, three weeks 
later and at the end of the trial; feed intake was recorded daily. 
On d 21 a sample of fresh faeces was collected from the rectum of six animals per 
treatment for viable counts of bacteria. On d 42 the same animals were killed by  
captative  bolt  and  slaughtered.  The  gastrointestinal  tract  was  immediately 
removed and samples from stomach, proximal jejunum, distal jejunum, cecum 
and the transverse colon were collected to determine pH, ammonia content, SCFA 
and microbial population. Mucosa samples from jejunum, ileum, and cecum were 
collected for morphological analysis. pH was measured within one hour from the 
sampling,  while  the  intestinal  contents  for  the  microbiological  determinations 
were  immediately  processed,  whereas  samples  for  others  determinations  were 
immediately freezed and stored at –20°C. 
Animal  housing  and  care  were  conducted  in  accordance  with  the  published 
guidelines  for  animal  welfare  and  protection  (directive  No.  86/609/EEC  and 
Italian Law Act, Decreto Legislativo No. 116, issued on January 27, 1992).  
Chemical analyses of feed and intestinal contents 
Analyses of the diets (crude protein, crude fiber, ether extract, ash and starch) 
were performed according to AOAC standard methods (AOAC, 2000; Method 
954.01 for crude protein, Method 962.09 for crude fibre, Method 920.39 for ether 
extract, Method 942.05 for ash, Method 920.40 for starch).  
Ammonia in fermentation fluid and intestinal chymus was measured as described 
by Searcy et al. (1967).   80
The SCFA in the intestinal chymus were analysed by gas chromatography (Varian 
3400, Varian Analytical Instruments, Sunyvale, CA 94089, USA; Carbopack B-
DA/4% CW 2M, 80/120, packed column; Supelco, Sigma Aldrich s.r.l., 20151 
Milano, Italy). The digesta were diluted 1:2 with distilled water and centrifuged 
(3,000 x g, 15 min.) and 1 mL of the supernatant was filled in microfuge tubes 
and  deproteinized  with  50  µL  perchloric  acid  (Merck,  Darmstadt,  Germany). 
After three hours the samples were centrifuged again (3,000 x g, 10 min.) and the 
supernatant  were  added  with  pivalic  acid  as  an  internal  standard  (Fussel  and 
McCalley, 1987) prior to injection.  
Microbial Counts 
Viable  bacteria    counts  from  faeces  at  21  days  and  intestinal  digesta  were 
performed using the ten fold dilution method and plating the samples onto Violet 
Red Bile Agar (VRBA), Rogosa Agar (RA) and Tryptose Sulphite Cycloserine 
Agar  (TSC)  for  the  enumeration  and  isolation  of  total  coliforms,  Lactic  Acid 
Bacteria (LAB) and C. perfringens, respectively. VRBA was incubated for 24 h at 
37°C in aerobiosis while RA and TSC were incubated at 39°C for 48 hours under 
anaerobic conditions, according to the manufacturer instructions.  
Morphological evaluations 
Mucosa samples from jejunum (1 m after pilor), ileum (1 m before ileo-cecal 
valve) and cecum have been formalin-fixed-paraffin-wax embedded and 3 mm 
histological sections have been stained with haematoxylin and eosin and measured 
by image analysis (Cytometrica, Byk Gulden, Milan, Italy)  to assess 10 villous 
height and 10 crypt depth randomly of each section .  
Statistical analyses 
Data were analyzed by ANOVA using GraphPad Prism 4.0 (GraphPad Software, 
San Diego, CA, USA) in a completely randomized design. Each cage formed the 
experimental unit. The differences among means of groups were analyzed using 
the t-Student test. Differences were considered statistically significant at P < 0.05.   81
Table 5.1: Diets composition
a 
Ingredients (%)  PHASE 1  PHASE 2 
Wheat  24.98  29.99 
Flaked barley  23.33  30.00 
Soy 48%  -  12.00 
Acid milk whey10%  18.33  5.00 
Biscuits  10.00  11.83 
Proteic Potatoe  6.67  1.83 
Yogurt  6.00  - 
Gluten  3.00  2.33 
Soy oil  3.00  2.00 
Coconut oil  2.50  2.00 
Lys HCl 98%  0.51  0.54 
Vitamins and mineral Premix*  0.40  0.40 
Calcium carbonate  0.38  0.88 
NaCl  0.25  0.33 
Fosfitalia 25/20  0.20  0.40 
Alimet MHA  0.14  0.11 
Tre  0.11  0.16 
Choline  0.10  0.10 
Phytase  0.10  0.10 
aas fed  
*Providing per kg: Vit. A: 16,000 IU; Vit. D3: 2,200 IU; Vit. E: 45 mg; Vit. B1: 1.8 mg; 
Vit. B2: 5.5 mg; Vit. B6: 3 mg; Vit. B12: 0.04 mg; Vit. PP: 25 mg; Vit. K3: 1.4 mg; 
Choline: 185 mg; Fe: 170 mg; Cu: 160 mg; Zn: 140 mg; Mn: 85 mg; I: 1 mg; Se: 0.3 mg; 
Co: 1 mg. 
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Table 5.2: diet chemical analysis
a 
Nutrients 
(% d.m.) 
PHASE 1  PHASE 2 
Crude Proteins  18.54  18.1 
Ether Extract  8.16  6.70 
Crude Fiber  1.27  2.84 
Crude Ash  4.58  4.46 
Starch  32.84  38.13 
Lys*  1.30  1.20 
Met+Cys*  0.78  0.69 
ED kcal/kg*  3807  3557 
EN kcal/kg*  2643  2493 
*calculated values 
 
5.1.3. Results 
 
Performance of animals are showed in Table 5.3. Animals preserved a good health 
status all the trial long. Some sporadic event of diarrhea occurred, but there were 
no differences among groups. 
When  compared  to  control  feed  intake  was  significantly  increased  during  the 
whole experiment by the thymol treatment by 15.4% and 11% during the first and 
second phase, respectively (P<0.05) with an overall increase of 12.6% (P<0.05). 
Growth parameters were not affected by treatments. 
Viable counts, and intestinal pH, ammonia and SCFA are showed from Table 5.4 
to 5.9. Clostridia populations were under the detection limit and could not be 
determined. At 14 d microbial fecal counts were not influenced by treatments. At 
42 viable cecal coliforms were significantly reduced by the blend of citric acid 
and thymol by 3.9 Log (6.7 vs 2.8 Log CFU mL
-1, for CTR and CT, respectively; 
P<0.05).  Furthermore  citric  acid  and  thymol  alone  were  able  to  decrease 
coliforms count of 0.7 Log and 3  Log, respectively, even if they didn’t reach 
significant  P  values.  Lactic  Acid  Bacteria  counts  were  not  different  among   83
treatments, but the cecal ratio coliforms/LAB  was reduced by  every  treatment 
reaching significant levels (P = 0.02) only for the blend (0.8, 0.7, 0.5, and 0.3 for 
CTR, CA, TY, and CT, respectively.) 
pH and NH3 in the intestinal tracts were not different among treatments. 
SCFA production was formerly affected at stomach level, where CT significantly 
increased propionic acid concentration from 0.10 mmol to 0.28 mmol L
-1 for CTR 
and  CT,  respectively  (P  =  0.0001);  all  treatments  increased  n-butyric  acid  by 
254%, 348%, and 389% for CA, TY, and CT, respectively (P = 0.0002), thus 
increasing the overall amount of SCFA in the stomach (+ 175%, +252%, and 
+297%,  for CA, TY, and CT, respectively (P = 0.0001). In proximal jejunum 
acetic acid was significantly lowered by CA, TY, and CT, (-38%, -22%, and -
26%, respectively, P = 0.01), whereas lactic acid was significantly increased by 
TY when compared to control (+74%, P =0.03). 
Morphological results are showed in Table 5.10. Only cecal crypts were affected 
by treatments, having TY and CT group higher crypts depth than CA group. The 
control  group  had  intermediate  values  between  TY  -  CT  and  CA  groups.  84 
Table 5.3. Growth performances of piglets receiving a diet added or not with microencapsulated citric acid (CA), thymol (TY) or a blend 
of citric acid and thymol (CT) in the six weeks after weaning 
  n  CTR  CA  TY  CT  P 
Initial BW, kg  24  6.58 ± 0.85  6.69 ± 0.85  6.85 ± 0.79  6.76 ± 0.68  0.69 
ADG, g d
–1 (0-21d)
  24  258.0 ± 65.2  267.4 ± 77.6  298.4 ± 65.8  288.8 ± 72.9  0.18 
ADFI, g d
–1 (0-21 d)
  4  412.8 ± 24.7
a  405.8 ± 38.9
a   476.5 ± 28.1
b  434.5 ± 39.2
a  0.04 
G:F (0-21 d)  4  1.60 ± 0.07  1.52 ± 0.10  1.60 ± 0.12  1.52 ± 0.14  0.51 
21 d BW, kg  24  12.00 ± 1.78  12.30 ± 2.18  13.11 ± 1.87  12.82 ± 1.63  0.17 
ADG, g d
–1 (22-42) d
  24  451.3 ± 129.3  481.1 ± 131.3  501.9 ± 83.5  458.0 ± 147.4  0.49 
ADFI, g d
–1 (22-42 d)
  4  702.8 ± 58.5
a  786.8 ± 39.8
b  779.8 ± 24.1
b  741.0 ± 27.7
a  0.04 
G:F (22-42 d)  4  1.57 ± 0.09  1.64 ± 0.05  1.56 ± 0.05  1.62 ± 0.06  0.33 
Final BW, kg  24  21.02 ± 3.74  21.92 ± 3.96  23.15 ± 2.88  21.98 ± 4.10  0.27 
ADG, g d
–1 (0-42 d)
  24  352.2 ± 89.6  371.5 ± 62.28  397.5 ± 62.28  371.3 ± 98.85  0.35 
ADFI, g d
–1 (0-42 d)
  4  554.5 ± 26.4
a  591.8 ± 32.7
a  624.5 ± 21.1
b  584.0 ± 29.3
a  0.03 
G:F (0-42 d)  4  1.58 ± 0.07  1.60 ± 0.05  1.57 ± 0.07  1.58 ± 0.07  0.95 
*values are means ± SD. Values within the same row with different superscripts are significantly different (P < 0.05). ADG = average daily gain; ADFI 
=  average daily feed intake;G:F = gain to feed ratio; BW = body wheight   85
Table 5.4: fecal bacterial counts at 21d (log10 CFU g
-1)
a 
  CTR  CA  TY  CT  P 
LAB  6.74 ± 0.25  6.75 ± 0.48  6.46 ± 0.49  6.77 ± 0.30  0.94 
Coliforms  8.77 ± 0.23  8.70 ± 0.33  8.62 ± 0.25  8.74 ± 0.39  0.99 
a values are means ± SD of six replicates per treatments 
 
 
 
 
Table 5.5: Counts of viable coliforms (log10 CFU mL
–1) in chymus from stomach 
(S), proximal jejunum (PJ), distal jejunum (DJ), and cecum (CE) from piglets that 
had received a diet added or not with microencapsulated citric acid (CA), thymol 
(TY)or a blend of citric acid and thymol (CT) in the six weeks after weaning
a 
  CTR  CA  TY  CT  P 
S  2.99 ± 0.64  3.25 ± 0.29  2.08 ± 0.95  2.65 ± 0.65  0.65 
PJ  3.16 ± 0.70  3.80 ± 0.24  3.35 ± 0.72  2.90 ± 0.66  0.77 
DJ  5.83 ± 0.30  6.06 ± 0.36  6.24 ± 0.22  6.04 ± 0.35  0.82 
CE  6.73 ± 0.25
b  6.03 ± 0.16
ab  4.30 ± 1.37
ab  2.81 ± 1.27
a  0.04 
CO  5.81 ± 1.17  5.20 ± 1.06  5.45 ± 1.17  4.81 ± 0.96  0.93 
a values are means ± SD of six replicates per treatments. Values within the same row with 
different superscripts are significantly different (P < 0.05). 
 
 
 
 
Table 5.6: Counts of viable LAB (log10 CFU mL
–1) in chymus from stomach (S), 
proximal jejunum (PJ), distal jejunum (DJ), and cecum (CE) from piglets that had 
received a diet added or not with microencapsulated citric acid (CA), thymol 
(TY)or a blend of citric acid and thymol (CT) in the six weeks after weaning
a 
  CTR  CA  TY  CT  P 
S  6.38 ± 0.37  6.89 ± 0.27  6.36 ± 0.39  6.91 ± 0.42  0.57 
PJ  5.67 ± 0.39  6.36 ± 0.29  6.03 ± 0.43  6.10 ± 0.35  0.62 
DJ  5.89 ± 0.38  5.69 ± 0.39  5.79 ± 0.40  6.12 ± 0.48   0.89 
CE  8.24 ± 0.19  8.42 ± 0.15  8.52 ± 0.34  8.52 ± 0.34  0.86 
CO  8.54 ± 0.27  8.34 ± 0.37  8.82 ± 0.20  8.97 ± 0.30  0.44 
a values are means ± SD of six replicates per treatments. Values within the same row with 
different superscripts are significantly different (P < 0.05).   86
 
Table 5.7: pH values in chymus from stomach (S), proximal jejunum (PJ), distal 
jejunum (DJ), and cecum (CE) from piglets that had received a diet added or not 
with microencapsulated citric acid (CA), thymol (TY)or a blend of citric acid and 
thymol (CT) in the six weeks after weaning
a 
  CTR  CA  TY  CT  P 
S  4.13 ± 0.25  4.04 ± 0.19  4.11 ± 0.30  4.14 ± 0.13  0.99 
PJ  5.81 ± 0.13  5.50 ± 0.28  5.70 ± 0.11  5.88 ± 0.15  0.48 
DJ  6.74 ± 0.24  7.12 ± 0.10  7.05 ± 0.30  6.86 ± 0.16  0.58 
CE  5.33 ± 0.05  5.35 ± 0.08  5.42 ± 0.12  5.29 ± 0.10  0.75 
CO  6.00 ± 0.20  5.78 ± 0.23  5.99 ± 0.23  5.85 ± 0.06  0.82 
a values are means ± SD of six replicates per treatments. 
  
 
 
Table 5.8: ammonia levels (mmol L
-1) in chymus from stomach (S), proximal 
jejunum (PJ), distal jejunum (DJ), and cecum (CE) from piglets that had received 
a diet added or not with microencapsulated citric acid (CA), thymol (TY)or a 
blend of citric acid and thymol (CT) in the six weeks after weaning
a 
  CTR  CA  TY  CT  P 
S  7.77 ± 1.32  7.40 ± 0.66  6.52 ± 1.00  6.61 ± 0.81  0.77 
PJ  15.40 ± 1.64  15.10 ± 2.02  10.28 ± 2.12  16.18 ± 1.93  0.16 
DJ  14.84 ± 2.60  13.78 ± 1.02  11.33 ± 1.36  14.30 ± 1.62  0.51 
CE  8.00 ± 2.06  6.24 ± 0.85  6.76 ± 1.11  11.22 ± 3.23  0.33 
CO  23.01 ± 4.24  15.15 ± 2.24  24.16 ± 3.47  26.01 ± 6.13  0.31 
a values are means ± SD of six replicates per treatments.   87 
Table 5.9. Short-chain fatty acids values (mmol L
–1) in chymus from stomach (S), proximal jejunum (PJ), distal jejunum (DJ), and cecum 
(CE) from piglets that had received a diet added or not with microencapsulated citric acid (CA), thymol (TY)or a blend of citric acid and 
thymol (CT) in the six weeks after weaning 
    CTR  CA  TY  CT  P 
              S  Acetic acid  1.66 ± 1.25  1.91 ± 1.11  2.51 ± 1.71  2.69 ± 0.93  0.48 
  Propionic acid  0.14 ± 0.10
ab  0.14 ± 0.0 
a  0.19 ± 0.12
ab  0.36 ± 0.20
b  0.0001 
  n-Butyric acid  0.96 ± 1.09
a  3.37 ± 1.10
b  4.31 ± 1.58
b  4.68 ± 1.20
b  0.0002 
  Total  2.04 ± 0.55
a  5.63 ± 1.83
b  7.21 ± 2.68
b  8.09 ± 1.33
b  0.0001 
              PJ  Acetic acid  1.11 ± 0.24
b  0.68 ± 0.13
a  0.86 ± 0.10
a  0.82 ± 0.24
a  0.01 
  Propionic acid  0.19 ± 0.07  0.09 ± 0.03  0.10 ± 0.01  0.17 ± 0.15  0.14 
  n-Butyric acid  2.57 ± 0.99  2.25 ± 1.01  3.37 ± 0.87  2.53 ± 2.06  0.54 
  Total  4.23 ± 1.35  3.07 ± 1.12  4.39 ± 0.95  3.73 ± 2.23  0.49 
              DJ  Acetic acid  4.18 ± 1.47  4.75 ± 1.20  4.04 ± 0.33  3.94 ± 1.00  0.75 
  Propionic acid  0.38 ± 0.46  0.20 ± 0.10  0.13 ± 0.04  0.18 ± 0.09  0.60 
  n-Butyric acid  7.60 ± 2.24  8.52 ± 2.80  11.23 ± 1.87  9.37 ± 0.70  0.30 
  Total  12.34 ± 3.41  15.19 ± 4.14  17.32 ± 1.84  13.92 ± 0.77  0.33 
              CE  Acetic acid  43.5 ± 16.0  48.8 ± 4.01  46.5 ± 12.1  45.5 ± 8.04  0.87 
  Propionic acid  26.0 ± 8.86  34.3 ± 3.53  32.0 ± 8.10  33.1 ± 3.60  0.17 
  n-Butyric acid  14.6 ± 7.80  17.5 ± 1.76  15.3 ± 7.04  15.4 ± 4.52  0.83 
  Total  87.74 ± 30.46  103.3 ± 7.004  97.00 ± 25.14  97.68 ± 13.70  0.80 
*Values are means of six  animals for each treatment. Different superscripts within each row are significantly different (P < 0.05).  
Colon data were not available.   88
Table 5.10. Morphological evaluations of villi height and crypts depth ( m) of 
jejunum, ileum and cecum from piglets that had received a diet added or not with 
microencapsulated citric acid (CA), thymol (TY)or a blend of citric acid and 
thymol (CT) in the six weeks after weaning
a 
Treatments  Jejunum  Ileum  Cecum 
  Villi  Crypts  Villi  Crypts  Crypts 
CTR  263 ± 75  226 ± 29  231 ± 26  210 ± 30  334 ± 37 
ab 
CA  273 ± 28  206 ± 31  218 ± 20  182 ± 24  301 ± 39 
a 
TY  266 ± 36  229 ± 25  233 ± 22  207 ± 12  368 ± 56 
b 
CT  237 ± 27  251 ± 73  217 ± 18  216 ± 17  376 ± 36 
b 
aValues are means of six  animals ± SD for each treatment. Different superscripts within 
each column  are significantly different (P < 0.05). 
 
5.1.4. Discussion 
 
The increasing need to find alternatives to antibiotic growth promoters focused 
research  attention  on  additives,  such  as  organic  acids  and  flavors,  which  may 
improve health status and growth performance of piglets at weaning. The transit 
to liquid “animal” more digestible feed, such as maternal milk, to “vegetal” solid 
feed,  added  to  the  stress  due  to  sow  dependence,  to  transportation  and  to 
environmental  changes,  are  all  causes  of  the  Post  Weaning  Syndrome  (PWS), 
which results in alterations in villus-crypt structure (Miller et al., 1984; Hampson 
1986; Kelly et al.,1991), and consequently malabsorbtion. During weaning the 
free  access  to  feed  and  its  presence  in  the  gut  is  necessary  for  a  correct 
development of intestinal mucosa, being the post-weaning anorexia a factor which 
lead to a worse atrophy of villi and to a decrease in crypt cell production rate 
(Pluske, 2000). In such a way the increased feed intake in thymol fed animals 
found in this study is interpreted as a positive effect, probably due to its properties 
to stimulate pancreatic secretions and brush borders enzymes. Futhermore many 
investigations on broilers observed the positive effect of essential oils and flavors 
on feed intake and growth performance (Bassett, 2000; Jamroz and Kamel, 2002). 
Even  if  there  are  few  data  avaiable  on  pigs  performance  Isley  et  al.,  (2003) 
observed that  feeding sows with a combination of essential oils such as capsicum,   89
carvacrol, and cinnamaldheyde, significantly improved piglets weights at 21 d of 
lactation.  
Another  consequence  of  PWS  is  the  E.  coli  pathogenic  intestinal  overgrowth, 
resulting in diarrhea onset and high mortality rate. (Kyriakis, 1989). The growth 
promoting  function  of  organic  acids  has  been  extensively  reviewed  by  many 
authors  (Roth  and  Kirchgessner,  1989;  Partanen  and  Mroz,  1999;  Canibe  and 
Jensen, 2003) and it has been supposed that it is more related to organic acid 
antimicrobial effect, rather than to the decrease of digesta pH, since evidence of 
the latter is difficult to find (Bolduan et al.,1988; Roth and Kirchgessner, 1997; 
Fevrier et al., 2000). Flavors have well known in vitro antibacterial properties 
(Burt, 2004), but little is known about their in vivo effect. Manzanilla et al. (2004) 
observed that the inclusion of plant extracts to piglets diet significantly increased 
intestinal lactobacilli and lactobacilli to coliforms ratio. Results observed in the 
present study are coherent with the previously described ones, since we found that 
both the blend of citric acid and thymol and the individual substances strongly 
affected coliforms counts in cecum and shifted the coliforms/ Lactic Acid Bacteria 
(LAB) ratio more toward LAB rather than coliforms. It has been suggested that 
organic  acids  and  phenolic  compunds,  such  as  thymol,  may  exert  their 
antibacterial action both diffusing through the bacterial cell in the small intestine 
and cecum of animals (Lueck, 1980; Partanan and Mroz, 1999).  It is therefore 
necessary that they can reach the lower part of the gut maintaining their structure 
and concentration bypassing the stomach pH, and this can be pursued by using 
lipid microencapsulated additives (Piva et al., 2007), that allow a release of active 
ingredients after they entered the duodenum as they are attacked by pancreatic 
lipases. This could explain why microbial counts were affected only in the distal 
part  of  the  intestine,  where  the  lipases  action  has  been  fully  completed. 
Microbiological data are aligned to cecal fermentation data. In the fermentation 
study the synergism between citric acid and thymol allowed to lower coliforms 
counts  and  to  increase  LAB,  thus  lowering  the  colforms  /  LAB  ratio.  The 
concentrations of citric acid and thymol that allowed to observe those results in 
the in vitro study were a little higher than the one employed in the in vivo study 
(3000 vs 1875 ppm, for citric acid and 200 vs 125, for thymol); this discrepancy is   90
not numerically detectable if applied to an in vivo system, because it is very hard 
to define a linear relationship between in vitro and in vivo concentrations, the 
latter depending on the amount of ingested feed, on the feed passage rate in the 
gut, and on the volume of digesta. Despite the in vitro results, no acetic acid 
increase was observed in the cecal chymus collected from the piglets at the end of 
the in vivo trial. In vivo, organic acids are absorbed through the intestinal wall and 
SCFA accumulate in the chymus only if there  is a saturation of the intestinal 
absorption capacity. Therefore, SCFA total production determined by the diet may 
not be observable due to the intestinal absorption that occurs in vivo (Biagi et al., 
2006).  
The  lack  of  consistent  effects  of  the  blend  on intestinal  morphology  could  be 
explained by the fact that mucosa samples have been collected at the end of the 
trial,  six  weeks  after  weaning,  therefore  from  piglets  with  almost  a  fully 
developed digestive system (Gabert and Sauer, 1994).   91
5.2.  EFFECT  A  MICROENCAPSULATE  BLEND  OF  CITRIC 
ACID  AND  THYMOL  ON  PIGLETS  GROWTH 
PERFORMANCE,  INTESTINAL  MICROFLORA  AND  GUT 
MORPHOLOGY  
 
5.2.1. Aim of the study 
The second trial was to evaluate a dose-response effect on feeding growing doses 
of a microencapsulated blend of citric acid and thymol.  
 
5.2.2. Materials and methods 
 
Animals, Housing and Dietary Treatments 
Ninety-six  crossbred piglets (Landrace x Duroc) were weaned at 21 d and were 
transported    to  the  barns  of  the  DIMORFIPA  to  the  Faculty  of  Veterinary 
Medicine,  University  of  Bologna,  for  a  post  weaning  trial  42  days  long.  The 
animals began the trial at the BW of 6.09 kg (SD = 0.71) and were immediatly  
divided after their arrival into four groups (24 animals per group), homogenous 
for  weight  and  gender  and  were  housed  in  16  cages  corresponding    to  four 
replicates of six pigs. Then piglets received the basal diet with or without (control 
diet) the addition of a microencapsulated blend containing citric acid and thymol 
at 1875 and 125 ppm, respectively. The blend was included in the diets at : a) 0 
ppm (CTR),  b) 2,000 ppm (CT2), c) 5,000 ppm (CT5) and d) 8,000 ppm (CT8). 
All diets were formulated to provide the same amount of energy, protein, essential 
amino acids, calcium  and phosphorus. No antimicrobial agents were added to 
diets. The composition of the base diet was changed after the first two weeks. 
Feed and water were provided ad libitum. Composition and estimated chemical 
analyses of the experimental diets are reported in Table 5.1 and 5.2, respectively. 
Experimental  Procedure and Sampling 
Body weight was recorded individually at the beginning of the trial, two and three 
weeks later and at the end of the trial; feed intake was recorded daily.   92
On d 14 a sample of fresh faeces was collected from the rectum of six animals per 
treatment for viable counts of bacteria. On d 42 the same animals were killed by  
captative  bolt  and  slaughtered.  The  gastrointestinal  tract  was  immediately 
removed and samples from stomach, proximal jejunum, distal jejunum, cecum 
and the transverse colon were collected to determine pH, ammonia content, SCFA 
and microbial population. pH was measured within one hour from the sampling, 
while  the  intestinal  contents  for  the  others  determinations  were  immediately 
freezed and stored at –20°C. 
Animal  housing  and  care  were  conducted  in  accordance  with  the  published 
guidelines  for  animal  welfare  and  protection  (directive  No.  86/609/EEC  and 
Italian Law Act, Decreto Legislativo No. 116, issued on January 27, 1992).  
Chemical analyses of feed and intestinal contents 
Analyses of the diets (crude protein, crude fiber, ether extract, ash and starch) 
were performed according to AOAC standard methods (AOAC, 2000; Method 
954.01 for crude protein, Method 962.09 for crude fibre, Method 920.39 for ether 
extract, Method 942.05 for ash, Method 920.40 for starch) and Van Soest et al. 
(1991)  for  neutral  detergent  fiber  (NDF)  and  acid  detergent  fiber  (ADF) 
determinations.  Gross  energy  of  the  predigested  diet  was  measured  by  bomb 
calorimetry (model 1261; Parr Instrument, Moline, IL, USA). 
Ammonia in fermentation fluid and intestinal chymus was measured as described 
by Searcy et al. (1967). 
The SCFA in the intestinal chymus were analysed by gas chromatography (Varian 
3400, Varian Analytical Instruments, Sunyvale, CA 94089, USA; Carbopack B-
DA/4% CW 2M, 80/120, packed column; Supelco, Sigma Aldrich s.r.l., 20151 
Milano, Italy). The digesta were diluted 1:2 with distilled water and centrifuged 
(3,000 x g, 15 min.) and 1 mL of the supernatant was filled in microfuge tubes 
and  deproteinized  with  50  µL  perchloric  acid  (Merck,  Darmstadt,  Germany). 
After three hours the samples were centrifuged again (3,000 x g, 10 min.) and the 
supernatant  were  added  with  pivalic  acid  as  an  internal  standard  (Fussel  and 
McCalley, 1987) prior to injection.  
Microbial Counts   93
Viable  bacteria    counts  from  faeces  at  14  days  and  intestinal  digesta  were 
performed using the ten fold dilution method and plating the samples onto Violet 
Red Bile Agar (VRBA), Rogosa Agar (RA) and Tryptose Sulphite Cycloserine 
Agar (TSCA) for the enumeration and isolation of total Coliforms, Lactic Acid 
Bacteria (LAB) and C. perfringens, respectively. VRBA was incubated for 24 h at 
37°C in aerobiosis while RA and TSC were incubated at 39°C for 48 hours under 
anaerobic conditions, according to the manufacturer instructions.  
Statistical analyses 
Data were analyzed by ANOVA using the GLM procedure of SAS (SAS Inst., 
Inc., Cary, NC) in a completely randomized design. Linear and quadratic contrasts 
were used to determine the nature of the response exhibited to the feeding of the 
citric  acid  and  thymol  blend.  Each  cage  formed  the  experimental  unit.  The 
differences  among  means  of  groups  were  analyzed  using  the  t-Student  test. 
Differences were considered statistically significant at P < 0.05. 
 
5.2.3. Results  
 
Performance of animals are shown in Table 5.11. 
The animals preserved a good health status all the trial long. Some sporadic event 
of diarrhea occurred, but there were no differences among groups. No statistical 
evidences have been reported during the whole experiment, and no dose-related 
effect was found, but the CT5 (5000 mg/kg) treatment gave the best results about 
growth performances. Compared to control the 5,000 ppm treatment numerically 
increase the average daily gain and the feed intake of  14% and 17%,  respectively 
since from the first period (0-14 d) (P= 0.7; P= 0.2); in the second period (15-42 d 
the  average  daily  gain  tended  to  be  improved  from  the  2,000  and  5,000  ppm 
treatments of 20.6% and 15%, respectively (P = 0.066) when compared to control. 
Final body weight was 12.3% higher in  2,000 and 5,000 ppm fed animals (P = 
0.087). The group receiving the blend at 8,000 ppm did not show any difference 
with  the  control,  even  if  during  the  first  phase  there  was  a  light,  but  not 
significant, increase in feed consumption and, as a consequence, in live weight at 
14 d (+7% e +8.6%, respectively).   94
Viable fecal and intestinal counts, intestinal pH, ammonia, and SCFA are showed 
from Table 5.12 to Table 5.16, respectively. 
At  14  d  fecal  coliforms  and  clostridia  counts  compared  to  control  were 
significantly increased by all  treatments (+1.8, +1.6, +1.5 Log CFU mL
–1   for 
coliforms at 2,000, 5,000, and 8,000 ppm, respectively, P = 0.0005; (+3.0, +2.9, 
+3.2 Log CFU mL
–1  for clostridia at 2,000, 5,000, and 8,000 ppm, respectively, P 
= 0.0036). At the end of the trial, coliforms and clostridia populations were under 
the  detection  limit  and  could  not  be  determined;  LAB  counts  tended  to  be 
increased in the proximal jejunum by 2,000, 5,000, and 8,000 ppm (+0.6, +2, +2.6 
Log CFU mL
–1, respectively; P = 0.12). 
Ammonia levels in the cecum tended to be affected by 5,000 and 8,000 ppm the 
former lowering NH3 concentration from 7.93 to 5.03 mmol L
-1 (CTR vs CT5, 
respectively; P = 0.12), and the latter highering its concentration from 7.9 to 9.6 
mmol  L
-1  (CTR  vs  CT8,  respectively;  P  =  0.12).  No  other  differences  were 
observed. 
Intestinal pH at was not affected by treatments. 
All treatments significantly reduced propionic acid concentration in the cecum, 
when compared to control (-30%, -37.5%, -28.9%, for 2,000, 5,000, and 8,000 
ppm, respectively, P = 0.01). The blend at 2,000 and 5,000 ppm tended to reduce 
cecal total SCFA by 17% and of 22%, respectively (P = 0.12), and colonic acetic 
acid by 28.5% and by 10.5%, respectively (P = 0.1)   95 
Table 5.11. Growth performances of piglets receiving a diet added or not with a microencapsulated blend of citric acid and thymol  at 
2,000 ppm (CT2), 5,000 ppm (CT5), 8,000 ppm (CT8) in the six weeks after weaning
* 
  n  CTR  CT2  CT5  CT8  P 
Initial BW, kg  24  5.93 ± 0.69  6.21 ± 0.57  6.19 ± 0.67  6.01 ± 0.76  0.41 
ADG, g d
–1 (0-14 d)
  24  241.6 ± 93.6  248.4 ± 99.1  275.3 ± 112.0  262.4 ± 108.4  0.68 
ADFI, g d
–1 (0-14 d)
  4  363.7 ± 22.0  412.2 ± 25.1  426.2 ± 56.6  388.7 ± 53.0  0.22 
G:F (0-14 d)  4  0.66 ± 0.06  0.57 ± 0.09  0.64 ± 0.09  0.673 ± 0.06  0.28 
14 d BW, kg  24  9.31 ± 1.34  9.47 ± 1.84  10.04 ± 1.89  9.68 ± 1.53  0.47 
ADG, g d
–1 (15-42) d
  24  435.1± 149.4  524.7 ± 144.8  502.0 ± 114.6  441.0 ± 140.8  0.07 
ADFI, g d
–1 (15-42 d)
  4  703.3 ± 28.9  795.8 ± 80.6  756.4 ± 122.2  693.3 ± 79.4  0.32 
G:F (15-42 d)  4  0.64 ± 0.01  0.63 ± 0.05  0.61 ± 0.03  0.61 ± 0.02  0.44 
Final BW, kg  24  21.06 ± 4.87  23.64 ± 3.95  23.66 ± 5.12  21.58 ± 4.71  0.09 
ADG, g d
–1 (0-42 d)
  24  360.3 ± 118.5  415.0 ± 89.6  416.7 ± 92.1  370.9 ± 118.3  0.15 
ADFI, g d
–1 (0-42 d)
  4  590.0 ± 26.5  668.0 ± 60.9  646.3 ± 94.4  591.8 ± 70.1  0.30 
G:F (0-42 d)  4  0.65 ± 0.02  0.62 ± 0.04  0.62 ± 0.03  0.63 ± 0.03  0.56 
* values are means ± SD.ADG = average daily gain; ADFI =  average daily feed intake;G:F = gain to feed ratio; BW = body wheight  96
Table 5.12: fecal bacterial counts at 14 d (log10 CFU g
-1)
a 
  CTR  CA  TY  CT  P 
LAB  6.54 ± 1.97  7.24 ± 0.66  7.00 ± 1.38  7.05 ± 0.91  0.92 
Coliforms  4.59 ± 0.40
a  6.41 ± 0.40
b  6.18 ± 0.21
b  6.13 ± 0.49
b  0.0005 
Clostridia  4.10 ± 0.17
a  7.13 ± 0.59
b  6.98 ± 1.56
b  7.30 ± 0.88
b  0.0036 
a values are means ± SD of six replicates per treatment. Different superscripts within each 
row  are significantly different (P < 0.05) 
 
 
 
 
Table 5.13. Counts of viable LAB (log10 CFU mL
–1) in chymus from stomach (S), 
proximal jejunum, (PJ), distal jejunum (DJ), cecum (CE), and colon (CO) from 
piglets receiving a diet added or not with a microencapsulated blend of citric acid 
and thymol  at 2,000 ppm (CT2), 5,000 ppm (CT5), 8,000 ppm (CT8) in the six 
weeks after weaning* 
  CTR  2,000  5,000  8,000  P 
S  2.96 ± 1.67  3.44 ± 0.85  3.76 ± 1.24  2.56 ± 1.49  0.48 
PJ  1.71 ± 1.88  2.27 ± 2.66  3.72 ± 0.61  4.30 ± 0.3130  0.12 
DJ  5.28 ± 1.03  5.42 ± 0.81  5.67 ± 0.60  4.55 ± 0.68  0.17 
CE  6.10 ± 1.33  7.30 ± 0.77  6.52 ± 1.05  6.15 ± 0.80  0.24 
CO  7.19 ± 1.37  7.94 ± 0.52  7.64 ± 0.70  7.64 ± 0.70  0.55 
* values are means ± SD of six animals for each treatment 
 
Table 5.14.pH in chymus from stomach (S), proximal jejunum, (PJ), distal 
jejunum (DJ), cecum (CE), and colon (CO) from piglets receiving a diet added or 
not with a microencapsulated blend of citric acid and thymol  at 2,000 ppm (CT2), 
5,000 ppm (CT5), 8,000 ppm (CT8) in the six weeks after weaning* 
  CTR  2,000  5,000  8,000  P 
S  3.86 ± 0.79  3.07 ± 0.66  3.10 ± 0.89  3.08 ± 0.79  0.25 
PJ  5.30 ± 0.55  5.76 ± 0.59  5.55 ± 0.30  5.69 ± 0.36  0.36 
DJ  6.62 ± 0.30  6.24 ± 0.56  6.24 ± 0.56  6.39 ± 0.42  0.47 
CE  5.04 ± 0.08  5.05 ± 0.39  5.09 ± 0.23  5.14 ± 0.19  0.88 
CO  5.61 ± 0.35  5.32 ± 0.27  5.78 ± 0.72  5.62 ± 0.43  0.41 
*values are means ± SD of six animals for each treatment 
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Table 5.15.Ammonia levels (mmol mL
–1) in chymus from proximal jejunum, 
(PJ), distal jejunum (DJ), cecum (CE), and colon (CO) from piglets receiving a 
diet added or not with a microencapsulated blend of citric acid and thymol  at 
2,000 ppm (CT2), 5,000 ppm (CT5), 8,000 ppm (CT8) in the six weeks after 
weaning* 
  CTR  2,000  5,000  8,000  P 
PJ  18.80 ± 6.74  21.06 ± 9.53  22.76 ± 5.88  23.56 ± 4.69  0.69 
DJ  20.06 ± 6.26  16.18 ± 6.82  17.91 ± 5.36  24.54 ± 5.16  0.15 
CE  7.93 ± 2.99  7.36 ± 4.20  5.03 ± 2.03  9.60 ± 1.77  0.12 
CO  31.53 ± 11.36  22.52 ± 16.40  39.21 ± 47.60  22.37 ± 5.27  0.56 
*values  are  means  ±  SD  of  six  animals  for  each  treatment.  Stomach  ammonia 
concentration was not determined. 
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Table 5.16. Short-chain fatty acids values (mmol L
–1) in chymus from stomach (S), proximal jejunum (PJ), distal jejunum (DJ), cecum 
(CE), and colon (CO) from piglets receiving a diet added or not with a microencapsulated blend of citric acid and thymol  at 2,000 ppm 
(CT2), 5,000 ppm (CT5), 8,000 ppm (CT8) in the six weeks after weaning* 
    CTR  2,000  5,000  8,000  P 
              S  Acetic acid  ND  ND  ND  ND  - 
  Propionic acid  ND  ND  ND  ND  - 
  n-Butyric acid  ND  ND  ND  ND  - 
  Total  ND  ND  ND  ND  - 
              PJ  Acetic acid  2.64 ±  0.95  1.55 ±  1.10  1.89 ± 1.35  1.56 ± 1.00  0.37 
  Propionic acid  ND  ND  ND  ND  - 
  n-Butyric acid  ND  ND  ND  ND  - 
  Total  2.64 ±  0.95  2.19 ±  1.54  2.09 ±  1.55  1.68 ± 1.07  0.70 
              DJ  Acetic acid  8.25  ±  4.35  8.35 ±  4.15  10.92 ±  4.24  5.83  ±  5.59  0.36 
  Propionic acid  ND  ND  ND  ND  - 
  n-Butyric acid  ND  ND  ND  ND  - 
  Total  9.11 ±  4.59  9.73 ±  4.21  11.56 ±  4.46  5.97 ±  5.44  0.29 
              CE  Acetic acid  83.75 ±  10.41  74.24 ± 11.57  71.03 ±  13.76  82.65 ±  16.57  0.29 
  Propionic acid  46.72 ±  6.65
b  32.86 ± 10.41
a  29.19 ±  6.21
a  33.23 ±  12.78
a  0.02 
  n-Butyric acid  8.63 ±  3.77  8.18 ±  2.21  7.75 ±  3.73  10.45 ±  5.22  0.65 
  Total  139.10 ±  10.29  115.30 ±  22.24  108.0 ±  22.32  126.5 ±  30.67  0.12 
              CO  Acetic acid  75.05 ±  18.46  53.63 ±  29.08  67.14 ±  20.75  86.02 ±  18.57  0.11 
  Propionic acid  34.09 ±  7.89  24.21 ± 12.91  27.63 ±  10.40  31.13 ±  6.60  0.35 
  n-Butyric acid  12.85 ±  3.82  11.93 ±  6.52  13.24 ±  3.93  15.90 ±  3.46  0.50 
  Total  126.90 ±  27.13  93.43 ±  50.31  112.10 ±  32.37  137.20 ±  24.17  0.18 
*Values are means of six  animals for each treatment. Different superscripts within each line are significantly different (P < 0.05).  
ND = under the detection limit  99
5.2.4. Discussions 
 
While large literature on the use of organic acids or flavors in animal production 
is available, little is present on the use of combinations of both kind of additives 
(Manzanilla et al., 2004; Piva et al., 2007) to achieve better results. 
In the second in vivo study we presented the effects of feeding piglets with a 
protected  blend  of  citric  acid  and  thymol  in  a  costant  ratio  (15:1)  at  growing 
inclusion  rate  in  the  feed,  in  order  to  find  a  dose-related  effect  on  growth 
performance and gut microflora. 
Despite a dose-related effect wasn’t found, the treatments containing the additive 
at 2,000 and 5,000 ppm gave the best performance results, being the final body 
weights of piglets numerically heavier than weights of the piglets fed the control 
diet.  Although statistical evidence was not reached, because of the low statistical 
power, the trend of the trial was positive, leading to the suggestion that such kind 
of additives could be a valid alternative to antibiotic growth promoters. Tylan 40, 
a commercial trademark of Tylosin,  was used as swine feed additive from 44 to 
110  µg/mL,  depending  on  the  age  and  on  the  stage  of  production  (Blackwell 
Science Inc., 2003; Si et al., 2006). In this study  the maximum concentrations of 
citric acid and thymol achieved at 8,000 ppm were 7.2 µg/mg and 0.5 µg/mg, 
respectively,  therefore  being  under  the  range  of  antibiotic  growth  promoters 
(AGP) doses. 
Regarding  to  microbiological  aspects,  although  explanations  of  the  increased 
amount of coliforms and clostridia in all the treated animals cannot be found, 
lactic acid bacteria (LAB) in proximal jejunum at the end of the trial tended to be 
increased by every dose. Even if the largest microbial population in pigs is located 
in  cecum,  it  seem  that is  the  small intestine  microflora  to  determine  diarrhea, 
especially  coliforms,  being  E.  coli  the  most  probable  cause  of  intestinal 
malabsorption syndrome (Kyriakis,1989; Buddle and Bolton,1992). Although it is 
known that the smaller the population of bacteria in the small intestine is, the 
more nutrients will be available for absorption by the animal (Canibe et al., 2003; 
Jensen, 1998), being lactobacilli the prevalent population of the small intestine, it 
is  generally  accepted  that  they  represent  an  important  source  in  mantaining   100
intestinal health status, as they compete with coliforms for adhesion sites on the 
mucosal  epithelium  and  stimulate  the  immune  system  (Blomberg  et  al.,  1993; 
Canibe and Jensen, 2003; Perdigon et al., 2001).  
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Weaning is a very crucial moment in the life of pigs; there are many factors which 
contribute to the rise of gut infections, which have an high economic impact in pig 
husbandry, especially after the removal of antibiotic growth promoters in EU. The 
use of organic acids and flavors as alternatives to AGP in animal husbandry has 
been  proposed  by  many  authors.  Despite  the  abundant  literature  regarding 
antibacterial activities of such substances in in vitro experiments, little data are 
now available on their real in vivo effects, especially regarding flavors.  
Aim of this study was to investigate the antimicrobial in vitro effect of organic 
acids  and  natural  identical  flavors  against  different  strains  of  foodborne 
pathogens,  such  as  Clostridium  perfringens,  Campylobacter  jejuni,  Salmonella 
enteritidis,  and  Escherichia  coli,  which  represent  a  threat  to  both  animal 
productivity and human health, in order to find possible synergisms among those 
compounds. The second step was to study their possible use in animal production 
to screen the role of such substances in modulating the intestinal microflora of 
pigs in an in vitro system simulating the intestinal environment and microflora; 
and finally, substances under investigation were tested in vivo to evaluate their 
properties as feed additive to prevent intestinal disorders during weaning.  
The Minimal Inhibitory Concentration results showed that gram positive bacteria 
were usually more sensitive than gram negative to antimicrobial effect of tested 
substances, and that organic acids were less effective than flavors. Furthermore, it 
has been observed the presence of a synergism between citric acid and thymol, 
especially against S. enteritidis, and E. coli, two of the maior causes of mortality 
in piglets at weaning.  
The fermentation study clearly showed the different microbial metabolic pattern 
for the small and large intestine. In the small intestine, thymol led the inhibitory 
trend of the whole fermentation parameters analysed, decreasing gas production, 
ammonia concentrations and coliforms counts, while in cecal fermentations was 
citric  acid  to  lead  the  fermentation  trend  acting  as  a  substrate  for  positive 
microflora growth, increasing gas production parameters and Lactic Acid Bacteria 
(LAB)  counts.    Even  if  the  largest  microbial  population  in  pigs  is  located  in 
cecum,  it  seem  that  is  the  small  intestine  microflora  to  determine  diarrhea, 
especially  coliforms,  being  E.  coli  the  most  probable  cause  of  intestinal   103
malabsorption syndrome (Buddle and Bolton, 1992; Kyriakis,1989). LAB are the 
prevalent population of the small intestine, and it is generally accepted that they 
stabilze the small intestine ecology, as they compete with coliforms for adhesion 
sites on the mucosal epithelium and stimulate the immune system (Blomberg et 
al., 1993; Canibe and Jensen, 2003; Perdigon et al., 2001). On the other hand, 
bacteria need nutrients for their own metabolism and compete with the host for 
nutrients  in  the  small  intestine  (Canibe  et  al.,  2001),  hence,  the  smaller  the 
population of bacteria in small intestine is, the more nutrients are available for 
absorption by the animal (Jensen, 1998). Whereas, in the presence of high number 
of bacteria in cecum and colon, the animal is able to utilize a part of energy from 
the nutrients being resistant to hydrolysis by host enzymes. Since the hypothetical 
mechanism  of  action  of  AGP  has  always  been  attributed  to  an  energy  saving 
because of the reduction of competitors microorganisms and to a reduction of 
microorganism  responsible  for  intestinal  disorders,  a  substance  which  should 
replace a growth promoter should therefore modulate intestinal microflora in two 
different  ways,  by  inhibiting  formerly  coliforms  in  the  small  intestine  and  by 
stimulating  the  growth  of  “beneficial”  cecal  bacterial  populations.  The  effect 
exerted by  thymol and citric acid in the fermentation study was aligned with the 
previous  observations.  Furthermore,  even  if  the  results  obtained  could  be 
attributed to the mechanism of action of thymol or citric acid in a preferential way 
in  the  small  intestine  and  in  the  cecum,  respectively,  they  showed  to  have  a 
stronger effect when used in combinations. 
Since it has been proven that organic acids and flavors loose their antimicrobial 
power passing through the acidity of the stomach, and that only a small amount of 
them can reach the lower gut, we  used microencapsulated molecules to bypass 
the stomach acidity and to reach the small and large intestine (Piva et al., 2007) in 
the in vivo studies. 
The  results  obtained  in  vivo  are  aligned  with  the  ones  from  the  in  vitro 
experiments. The presence of a synergistic effect between citric acid and thymol 
has been confirmed in the first study, where the microencapsulated blend of citric 
acid and thymol strongly affected coliforms in cecum, decreasing the number of 
viable cells by 3 Logs and the cecal coliforms / LAB ratio, therefore supporting   104
the  growth  of  a  beneficial  microflora  rather  than  enterobacteriaceae,  that  are 
harmful  for  intestinal  health.  In  the  same  way,  in  the  second  study  the 
microencapsulated blend increased the number of LAB in the proximal jejunum, 
which is a tool in improving intestinal health.  
The  use  of  a  blend  of  citric  acid  and  thymol  can  be  a  useful  instrument  in 
controlling intestinal ecosystem in the absence of  AGP’s, since it has been able 
both to inhibit pathogens growth and modulate microflora in vitro and to improve 
intestinal  health  of  piglets  in  vivo.  Studies  on  the  reduction  of  foodborne 
pathogens shedding at slaughter could be the future perspective of the use of this 
technology to improve meat safety for human consumption. 
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